ISSN 0913-168X

がん集学財団ニューズ 40
Vol.

JFMC［Japanese Foundation for Multidisciplinary Treatment of Cancer］

公益財団法人 がん集学的治療研究財団

JFMC!Japanese Foundation for Multidisciplinary Treatment of Cancer"! (&),/+'-*.%!"#$

1+2:>9$%8-=4E0/2:
,; @A

C3F

"&('!)*.5,67<B?D,;#ØR"ÐLBÏ8QÄÏ8_÷TQÇPP4>5AGwk QYN"
(r%n{u%k~%)=PæKALn"(9c)N45W©PK4L"

N45ÀaSp^QþPY;GPä](cM:V>_VM[]*°4i6ÞbÛK[5PO]VAG&¿ÎRJc£ÜsPþÚ±bð'!

AG!

wí»®Q(e)NYÀ6^(r%nQÿý)b9cRîz/0&+21+'L[]"a9ÊQ×a¾

7\C^r%n{u%k~%QèmýP<hA"+

Q5b&XL4VC!9ýR.÷P+÷"ëý

;8\FQþPøvALV4]VAG!wí»®

R0÷P+÷9"9cMa;O\_L4^NQ>N

Qgfqe%#i s%#jlq|b8\MC!

ã@c?c÷H<MO;"?/Zk÷")]ï=L:GBÏ8Qä](W9"¿ÎQ1Ö#

FrC1;Q÷$QRAWN?³ybÔ5N"FQ

PVG9^4ªgOwíÙ½bNNC^2üTN

,uR$4OYQNO]VC!

¸àAL4^QM3]VC!

>QÊd>6P3AL"-*LïQ=:P{J

1;Q9cQ¦¼ÒNOJL4^Q9"(x)Lä](cM:GQ9"BÏ8M3]VC!48P

M3^>NbÆ6^N"­.Olx%tMÉxâAL>Q9cND58"3^4RT<HO4YQM

b·6KK3^dkdÊP74LY"+Q9c3^O\"M:^Á] ã@cQ(!)QßbÉX"sQèmý9-AL;^>NRfOM3]VC!

¨¢bSAL3=\_^8!åés_"]á's

9csQö?R"ØGIJc÷Q!b[]t;_"Å9cÍbl4Gs_"¡zs_" ã@C^>NH<PqV\D"JcQmysv%ÃcZ?/QñQhdbC^"ôs_N"(

QêNO^NýYSXL4VC!

ã@cQbW)b0èA"4aSQÛL^vbCU

9cR"@c?Ýõ"?/"?k÷"FrC

LAB^Q9(ç>Üs)HNoAL4VC!

P4K«>^8Y:_O44[õ²Oi6MC!9IP>Q+*LRÌÜè`oÚ=Q%o%jpzcsQö?R"÷$QRAWN$bbz\=^>ãPZ@A4£jXs_)bµ="NPàPÈº4GAVC!>Q9cNQD4bÊû$QwíÙ½bÇOJL:VAG!FQoMb´

Z¥±PKEJ:]PED"ÓdQ@c"¥±Q

2CU;V4G(E:O9\M:^9cs)N^$PFQèmýb@6"ìAMY1;QÕbH45}rùR"ÐLQ(9c3Ñúö§c¶)L4;>N9"ÄÏ8_÷NOJGBÏ8QËJQÂZhUNALòGP6\_G(9c ãQæQ6M3`5NÆ6L7]VC!@cQ?Õy)b%ä]AGYQM3]VC!

?¯vb[`A;7¤4óAï=VC!

QYNP"
(

Yþ,0L+¹¬J１"#)'(*%&!$;2<GLC%0A6H?P97<G/!">DF8%01P#I5+)-*&ON3'$!!JBH?P+:K4/M=()@.E,!!

+%-593#$1&7/>*(-5=.6 ,/

2:!'84&;<)0"pè]O"*µ//&+32*'~LÕ?,>Â'®
Nè]7I@G"¨~LxcÓL67I@GNÚ5¢¤ëôQn×_H"©Ü#n×´K:O+**L\@S@C!

}?]" ª-*~£N³ìIÁB_$MG:S@

I=^H"±)óÎHO"rÆ @LY\evidence

C!SC"é~.ÉLÓè]7LÙ@"1É

I@G&f÷®9¨­?]G5SA9"±)Ð0LÙ%I(X-¶+*~NT)ªºNùHO"uM³°HW"¬üN¶X+1"d­h_£á@"âít_íVS@C!¿7INW:ÀqOEàH"÷®ÔWrÆ©fIK

K5O"±)óÎHN![óÎ9ÓõÁI@G\0Û_S;ÄÎ@SA!"«­¸N&f}?]CjH"µÙ9ÇÏ@G5\{NÐ÷®NJ]_FZA\8Oý÷Næ¯LR@"

18Z¡H:\<9¥¯TZ]"Ñ÷®

÷®ÈWpHK[SA!@8@"Ô_¢OH_ð@C±)óÎNûÐ9¶U?]SA!ND":\rbcw%d%X+²FZ´&_÷®GL¨­pè]HO(X-¶+*~NT)HW.@;-@H:]P"¬üL·A\I=^9W:;"=NÑ

S@C9"EBM LWIF; & f ÷ ®&current÷®QNi£9(ö;VÃ9`÷®)I@G"

best practices'N¨­NCV"S;N±)óÎ_pÓè]79þ[JUR:ã$¥YLK\Ii£@"+"***²_a6\W¹±)óÎHW¶¯

Ø6G5SA!

zL+²:_a6G#AH:"lt%qHg

ª"®OøÎ²&Result oriented medicine'|%r{lm~n%qLs\H:\ûB_§wH:

X^ú&Learning oriented medicine'LWIF;

G5SA!

¬üT&Narrative based medicine'I?R¬ü "9 ` ÷ ® O Translational research&TR'

NÖ&Survivor oriented medicine'X®rÆ_±)N0HH:\&from bench to bed'ã&Health information technology'L´F; Evidenceg H"Äå²·N_HWÌ¾(=õÁ_¡based management&EBM'LY\Äå´ N¨­9DÅQ@"±)óÎNYI@Gä¤@"Kó´H4[SANH"=]LY[Value based CancerÎHO8Ì¾_C@G:S@C!BNÈ"RT

Care&VBCC'9«=A\I¬ @G5SA!

PCR _¤5CÞ9_jbphzo~"v{x~òJWÓè]7HO"ö;VÃ9`÷®_¦<|°LTA\¦ÿrbcw%d%"WÊ_oN½VCÑ®"b3"Hbilp®Ni`®t"W`°LTA\â²ÍîI@GN£"IHÔfK&f÷®N¨­"ïI

CEAmRNA"â#6Ù°LTA\ HER2 k¬ü&P'Nxou%ky~N§=q_ea}%î  Ð  m&+".**²

qI@GßÒIWi£AR;"2uÞl°A/'"Oxaliplatin N 5 Ä y< L T A \ GWAS  L Y \  © f  k î@&+",**² /'q$NËê_ÙEG:S@C!=]
ZO"ÐçS;NÝz¤©H@"b~sfp
２\'RH4[SANH"$N>ñ">ðv">¶Ne_»@;7±54@/<SA!
=,0~+É¼{

JFMC!Japanese Foundation for Multidisciplinary Treatment of Cancer"

0 '$#%).(/"*&+!-,$/9>)5,'%<:(
1".6+&¿5@9^DaU":eã>Ø±¢É2S

3)7CM?$%=+G9S/-7C

å`N?bXML5`]6QÏ5XD:"ÀQ

R8 IH

T

"DJ@OL0A2*;651P#ºyÉ2iõ:eã>Ø±¢É2T"é//×QâOBGS["9@|:4`S9[4aP5N56[5GBL8_XD!
:eT"ÒS¥]Sfl$h9^'U²MØôZL"ÝQyB5Øhi:UAa":eS
$Ä_duL['</øBL5<?N:"Åp>.NBL¡Z^aL5`NÏ5XD!

%+32*&R0¯Q¼ûHëtù§çSÉ2iõ

:eã>Ø±¢É2:"÷XN[FSÍsd

NBLÿAa"~é/0%+32+&R+,¯QK;ºöÁB"Åp>k:øâAa`?Nd5KK"y)ôiõNBLPAa"bø,/%,*+-&R.¯D±¢É2SÀP`U?dJL8_XD!7

QºyÉ2iõQúÙPAaXBG!?SÎN

L"vSÔ:"t>P?NT55L85L"¨ZLr4`±¢É2Q"tN|Sr5Ô:Ü­wSî\Ødß=`+S Ú>Ö#Q

×NBLÊD`?NQP_XBGST"?S±KPOBL"juTu>QM[D±¢É2S8xQ¢É2QæZLÛ¦9^xvd7G5NSr½

K?N:åaU¾5M4`NÏJL8_XD!

dß=L"D±¢É2ïO×SmBùàÓ9^Æ¹N[×cVQªÝS}9^S@ÐJS:4JG?N::þS«M4_XD!mBÓNT
^TsP_XD:"IC-SIûM4·M4
JG?N9^üd=^aG[SNÏ5XD!%õ

="85òBí>XD!
)))?"32.8#-(*=;'74$!

SÔQ:å`S9N\odCL8_XBGN?b"×q§8S¶A¬Ó:8zBQP_":eS'ã>Ø(SSd@!t9;"?aSGZS,ìêdgB"FaQG®>ÞiQ]_ý3)7CM?$%=+G9S/-7C

dÁ5"]_»>PØid1¡BL5<?Nd

R8 >N

0JL5`±¢É2HN56×d4_XBG!¶A

4"&('!,:*;BK<FQ*E . CEO#×q§8SQJW5!tdß=L"'ã>(N5
6ro[åL5P9JGÔ:"YP:^[

LnV NIH%National Institute of Health&SfÜ>Â°Q|å`SM4aU"8ß=BLY¤N<µQ­ÇIzS"vqvSlnj$NBL]6NSÏ5QÕ_XBG!

ÊBL5`!dÅT NIH QPeNR-6{SÔ:Ü8dBL8_XBG7Lûsg³(¸Ü{ÌdCMB"t`wS±¢QÑåBL5`!

T"ÜÂ°×¦SuNBL"é-/%+30*&R

XG"xÅMT"bø+3%,**1&RQt`wS±

Qøõ[S{l"ó3"ØQD`±¢NóE¢U{ÌQ-"/**}{dCCxÅVNIH%OSCHR&

du>NBG'7Lûsøõ[±¢ç(dÿBLdIí>"táeË¦Sfik$gmn*ôd

8_"é0*%+32/&RQTñGQ'FN[±¢ç(¤~BL5`!

dÿB"bø+0%,**.&RQ±¢çdGÃBÆ

{Ìd£åAE"FaQèBðdK=L²]6²X

LQÕJL8_XD!
:eSØ"±¢NT:þ>PªTP5±¢ç
MD:"ÔT´ÈD±¢çSZuhLnV NIH T¼#a#­Ë9^äS

vdqZL8_"

RSLnV NIH d&ÿD`c=H:"{ÌT©9+"-**}{"AL?aMtS]6P¿WpQ`３"#)'(*%&!$
8Ð¿jUC^SM¡>2KfaX=YIN¹°W

05-/2%*"#

öiFfjV9!

).!+4$$(%
3'0,1&]AXvy#n}#vyX&xj
jGMÚ"9MN9MjAÈj)T9PRaac,%-6B5#$2'80G+(-6Egf]Ug@YV9XN>*"JXM`W²»R

F. C9

c:Tö9"g@Xª WsjGR9MN?

DE=!;<4?:)C1@2*1&A3>/7"+NPO §Gª=dª >9V@VfCTjµ9áIf¤,j»O>BM!Þ¤­"Ä­TÝîp§GTGRXCMVwz%|WêG"Â

TaWáN\XUÇ|ijªª ¬¤#ª£Ã

ó8f+>k/¬|!½Ð¿îp,X­Wid

TTaWá9"M02)0./0*

KR9MN@CTWVe^GM!5X9L=Q>kXE½¤.¦zSYª X*·¼Xll{j®'X²T9:CTS"ÜWö:TÿWV:O)fCT>S?M!

X1Ea¯HR9^I!

M00)0./.*"YH3TØ:G"LgjzIfaXSaV9

ùY M1)/77/*W&Ú"©bÆ)Xk>"ªSYLg>¢?WÃwEg"½já:a

õ*SýÍ#ýÙbr¦áNX)íjÊÓGMÚ"XYMNPS8gT9:v>8f!G=G"_

M/.)/776*=dª&SãÁ'½b©ô]Ú

hTGRYJ¨Sçaã#TöigfªX½

X£Û£ÒK"½£ÒîNVUX)íjoG>g@X½0ý'Xl?V¸QXaTWMe»P

R?^GM!LXçsX M/2)0..0*"12èXR9fT9:Õ^Mfý$YÞ@ä¬WDGR9

ÿW>k>ÑQ=e"Æ6æVUa8PR1V9!¨uIf½Wüø`j=Af»ÅX_>

X*3"à>kë!½"¥%[!½"½§

áGR9f!ÄÁ>FáGM×ìXªX½

j+A"ð6Ì"³/.WiMf!½j-;Mj÷;fWYåX15tSYddJ3.t@d9>+>kum%,SI!

LCLC}WV½S8fT(uGR9f!

CX hÓ=d"g@XCTj¬[^GM!L¦"³ÅX!Ó>d_X=ýjÂW"³g^SXµVGW¶ýW79R9M+xp}oÅ=dXÐ¿WiIf÷>Ö;GR9f!³ÅY~o,&&!®'TVfT(!WØ92IW

LX­jyH,j8BSÈj9"0Åj¸Y´µ>·S"U:We2KZ99=ïjÉe:TÁW"¹Xj&¤W±ÔIfº­jþ¢GR=dEòWÀ_^GM!"Xµb!½j

Q!LgY"9QXW=J&¤Wä¬W¯PRº¥GVAgZTö:¦S"qeM@aV9T«@fYJN!

jGRG^<:TIfBX¶g!!½X\nYLX

îpX&¤|ºj¯HºýX«TjGR9ÚXGRX8e¦jË`f+GRX\n,S8fC

f>"³ÅXÊ'X®=dÑRîp>îN|W

T!>kWVPR5`R$¯GMCTSGM!L:Î_WEg"?f?¾9Ð¿>VEg"ä¬"GMhÓW)íj;" M/3)0..1*=dC

Þ@YJ¨Xg@XG$XÎßWâÏS?fc:t¿GM9TöPR9f!

ù,W¦m*j³4²ÃéG^GM!LXsSa--

0./20Ì¼-+®'Xû~ ¶'Xû~,)ÚW+>kTçlX|{qTVPMX>"+>kiñ´ª§,M»Wúf'®'MOXZ9(SGM!
mz%{|X½SY±SV@Ra§ªX
½@¤>*S?fc:WVe"

M/2)0..0*Dh=d">k®'#ed>¡TX}{r#rX¥<j`;"Y±XMbOG9½@¤X{Àj¾`"J¨4X!½b°Æsl>{４

JFMC!Japanese Foundation for Multidisciplinary Treatment of Cancer"½DgS9\\e+DgfxV>k±V8e

QFf-CQj óEO9f_P"÷><$j9P

j!¡T¡9ð_\EJ!÷þ<`,>k¦-P?fWÑdgOW9\F>"ç^VT³

8fdQªqj¾TE"·ùTE\EJ!IVP

EO°ã£QEOV¯6j<hI=TES9c:

;W!¡V¾­jÒY"à¡aFjq=EOE_O\9e\FVP¸E@<´9;E5B\F!

17*2006+|VE¯[QÿjÉY\EJ!
`Lhk"Cg\PxV±"VÌ<gSp?

DO|VX1£­ù¡"¹¡"IEOX2£V­ù¡T<9O(àVËÙTÞÌFf)Q9

V<=BP"B¤æß@-V±>%AdgO9f:gT±]O"lç^QEO~òTÖAO"

CQT¬"V1>QEOW­#EO9\F!JK">kV§"ý±T³FfhGS7Ô¦j=_O

5·Vc:T"¡YKQ=MO9O`±"KA

9@CQ>9¹°3Dg"òÔ¦ÝäV¦å>Ä

PW;dgS9CQ>8e\F!Cg=dVaßSFfYQSe\EJ!ICPceÕ®gTC´!¡V_PV±V8ejR:Ff="¬"àgjÜMO9@5P"ç^uþPV¦åTW(ºQ±""ÜF\l"d>Tµj*UOÎ+EO"§ím%P=SeVC¤>8fQCh=d"

9=UX¯LÜ=S9¡Y`ìJEO9\F!Í¼

÷>¡bj_f*{e NPO >+v}zm

j?=EO9@T`!¡V­¢> «SüVTSM

q&s?=¿¹¡"YT­ùbVzT8f

O9\F!

*!+
xHª'®§¿¡QVr &s

C:EJ!¡7Djo\;"ç^V:JS£©QjfDGO9JK?\EJ!FPTÓ"Vx

EO"¬"àQTµE"áÓV>k±V8e

Hª'®§¿¡W|2Êj,OàHª'®TFéfÐSRjÜ:CQ`ø¢TygOWR:P§Ê²-Qe_"±uwx}Q~òjT4

Eb:=!³2Í¼SRV¢PÿKjJkP¬dTv}zmq&s?=¿¹¡QV¿åPògJCQTÇjENN"DdT"!¡T¦=gÔ¦Ý¡jÜMO9fQ9:ÿK>8fCQjJÔç^QEOV:JS£©TN9O"±"o\;O"lç^TTEOCgTë FfÅPVªP8f­ùV>QEO¥DkQÛ;O9AgXQ

qjfDGOc?\EJ!
IVÉµWQkQk}ñT=]"§í`ô+´MO9\F!
///

4(12&!'/$
03+),-&).%*"#.'/7<5#$2):1>-,/7

*0 8;

+=

!%&%63()-,449"

50>plDg"X4£jA;fòÔ¦Ý
¡jN2^SQç^V¾åTOE26*2014+|1Ê31xT,Hª'®V§Q>ký±-jy&
T"ÚÂV,vØ`~&*e170+TO17
ü30=d2ü²T»ZÝ¡jûNCQ>P?\
EJ!á|VÊ²y&WxHª'®§¿¡>ÆBf,"w1"êR-Q9:u&oV:L,Rq-Q9:CQP"Ý1W,RqWSH«=$ 'ÿõ®100.Vqós'-jkQ×ï

>ký±Í¼"tTIV(¨gý±Í¼²T<

MH*.irW¨W¨V#vv¨#u&

9OZEJÁKj`Nç^V°ùT?UDg"{t&vw&,À&+>"IEOÝ2TO

|4Ê=dIV8Lj\iGOc9O9\F!e,>kPWöSS9J_T'>k§QæM]ý±¯Tce\FQç^W",>kV(¨gý±T³

TN9O-QYEO"ç^­ùbVâý*MH

FfÍ¼j0E0FfQ¾T"CgT³FfE

*µW¨©À&+>"úde=eaF@"

VnÈ¢IVjÜ9"¬"T¥E@«N¬"V

TSfvªV<µj"þèVn u{yeVu n^ý±ÕjceÕ®gTÿÏFfý±j§¯|*ppt z&w+jÃîDgO¶Dg\EJ!

E"`MOàVËÙVÖ5TÞÌFfCQj gë"W130¨P"/¶VW)wT[E５"#)'(*%&!$
DgJR89¿i9fBR=Q>JBRWCl¼=jRJ§I=jVï¦$°¦UN8PW"VðeQEJ!BV+E8pUN8PWqAKREPPºÒ=Q8P;e"DdU"Û¬÷7

þ}±YUäZ\<V HP UÎDg

ÑVPUce"S?V~V=jï;$°;

P8]G!<zCÛ¥]>"tUÒ@PVæ×U

WPºÒU7fBR<d"=jUVGfªbTEP]@gXÓ8QG!T;À£ØòQ7fB

ôªVva"LÞSBQ`|#bT=jªiVÎÙUN>]EPW"!rvr"W@B

ü@fò=!£fU=V?{=²?®_dgP8]!\<V±çinP8]GBRi~Ê\E]G!

G!

,

,

BVc9T/³ih]:"fäZR8JE]EP,`ÞVîåUE¶bUæG[>RVw[U§O>'$#%*+("&-!),

X0ó V = j.-< t H ¨ V

Q 7 f" >.5(/--3)te<dÐA­j*V¤Uce".#Þ7Ã¯÷V(Z8ò´"/#ÞZVq7Ã¯÷u

4(8@F>$%=*B;I2,8@

Åò´"0#Ã¯í÷ ò´".6(/--4)tec:H/A 3Ce1#øûÃ¯÷> ò´V1NVÃ¯ò´iØJ0"*6F>-7*)DG15&I?*&*E9!+'.<#MP>]EJ!DdU">/-(/--5)te<dWÐA­j*<dV¡CUce=jªV·Pji

4tei¾:fU7Je]EP"¯T=dfä

8fJ_.#-^2Ucf>ò´ /#=jª:

ZVÉ/RßÌVcUN>]EP"[DHP8J#Ò,ìmò´UN8Pöî\E]EJ=">/0

K>]G!

(/-..)te<dW"ÖTfò´VWi8fJ_"

é_U"fäZW")®22(.65-)t3ÀU"Ð

WM0V*q¥ôª+Zò´iØE]EJ!

A*µ$¡VäZ7REPF§"¢)®23

ÞV=jVÃ¯U¤EPW)®26(.651)t}Ú"(.65.)t./ÀU$nDgU¹hfo_ÎP6.-<tH¨UcfúeM^i96EP>]EJ=7REPsDg«'ñÆiùURGf>.3(/--1)tUå_DgJ*X0óV=j.-lt

VäZREP;;cI00t£UhJeIVèiOÜH¨+Qý©RTe]G!

JEP]8e]EJ!IV£U;>]EPW">fäZVùJfò´Vs'xRE]EPW"øû

.2(/--0)t<d÷UE8=jª*w|

Ã¯÷V%>VJ_.)
t.Á.--i.-Á /)ë

okmt"+i§L,A"j>T=dôª=Q>fxÌõùb«'ñÆ%|#bôª<dË ôªZ

£=jªiìEJ«'ñÆi96EP]

0)©&¥Vå%ÏT4iN?ÞU`° 1)
Þ8e]EJ!

p¬YSÞ£V«'ñÆn{'wZVæ 2)»$E<E"=ÞU;@f=jVÉ/iÄfR)®

Ôk%ÎÙà"ëqyu'gVá 3)
I23(.65.)t<d=ÞVïÇVX.~RTe"

VR%äZvz'p"=jôªV7b^gVØiÉãUðMP;e"ÞVA¬YÂÕURMPÿ

öîEP;e]G!

WTYRTMP8]G!Bgih]:P"ÞW"]J"fäZVò´W"ÞVV<8Í¨)®26(.651)te<d*V=j.-<tOÜH¨+~Rç%REPE¶bUæ8JK8Jç%

i">3(.661)te*=jÝ4.-<tH¨+

yi.äREPDgP8fòi¢UF"1

iå_E"=jVåUúeMjQ>]EJ!BV£"

l1Uq&"G3EP;e]G!ßÌR`"C=jVå=W>?6cE"=j"ê­½=jTS
Vï¦W"W>?È&E"Bg]QPºÒU7
MJS?V~V=jï¦$°¦W"â¸.-t£QP=iTLUdFP8]G!IV Q"r６

ìmC±Va«E?;¦85E,A]G!

JFMC%Japanese Foundation for Multidisciplinary Treatment of Cancer&(!83010:&=("</1;%2+59>7*36,-).4#'#$
Å25¼7l27»#¶$ W

JNLMKJO® `\c¬¥=b!(,+&'*-$#%)"
Å25¼7l27»#¶$<·¯='­3d10¼=ÈA(¾ae½9rU¯ÊQy[\H^147²-@26!·»>)lq=¶Ï»8"iµ§ZY¬\=»826,"Su k¨Ò±¦¢HB"©|+
D70ÍÎ=¦¢É<0Õ¤²-"\H£E/7²-@26!@6"t¢Ö¹+Dp !×Rmxh±+DHE"sÖ\T=À9e½Âª³H147²-"q<¬h±9¸ Ã¬`R`Ä  ¡g+DºÆzVHE"X<>¬ÇvÁ=°8Ó8-"{G47~\<C«.=¦¢<¤²-@26!}]"5=©_ÐH@9B"Ì<j147²-@26=8"¿"0Ñ²-"0Po;:F?w*83!
rU¯Ê ,I`´Ônf¯ Ò± Ë

3*5=C;#'9->7D215=!<3/10?%B&"A.0@$3*5=C;)4:+, 86<×+)*,Ø/v+/×%Ñ& *,",)$*."*)¶®

;G=D<;IÇ%`\e& Å¿5d%-_&1&'0!,$%%*,",)$*."*)&
^ 5

Â\

\ËL

TÈæ»0:©`Î"xmÈ>C@#FHa

ípË

~Ð )r
ñò÷&

\¢¤Íöîû\Ë

JFMC ¸TÈæ»5ô¬9«23ü*!+ðg9¡7Ë

Å!Å`îûn¦

À' ú¾

U

£

q¨Å`îûn¦Ou'Æ3g10Ø5ä8(%iÙ´[4È5Ïé&Ë

KÉy0:AHB#îûÂË

U£

TÈæ»0:©`Î"xmÈ

àS øì
ÿË

 ªè

%£Û±l6iÙÞÃÌ
¥µ£ÄÛL

âÒy!NYÅ`îûn¦Já #

(#+/2."),$%
~Ð )r

tMå

TÈæ»0:©`Î"xmÈ

1 « ¾%Õ³N¼pË|¾%Õ³wpË

Ô ß·

È{öQ

õëjkù

TÈæ»×ëN"hÚÜXhÖïÿ$°z?G#E

iÙU

ã 5

ípË

Å²Wc0:W`"æxm\\Ë

~Z

!(

ý

'fbçxm5}o4¯þÏé(ËÓ]ÊVÝRRË

ë ­P

U

£

ÅÅ`Å`RN`sxmYn¦¹½§

êN\óº'0*-%%*."+-$*/",)&\¶ JÁ5d%._&７

"#)'(*%&!$
B83I=2-)4*."9<3/(6?E*4+!

! JFMC 81-2;@9)C6,5&'DE!FB/,4*

2AJ/ SV1@*7 3 GF

J;=YJ/ SV1@
H[ UF GF

*7 3 GF8-$W<.D$W<"0>37.(2;)<A#"$:3/10=)?+%
DG HP QFK3B8"#J';&%L3O5$/CA3F>@:107MN*4*,!

８

6,:KPE"%B/N?Z40:K
X>M 9? CQ GF)L5"%&('! SVIM
O+ TR GF

9? GF$#8-

.D$W<

JFMC
!Japanese Foundation for Multidisciplinary Treatment of Cancer"! $,%*&#!")+'(
*L('H9[

2165V¹hQ<VGh:§>[¼k847¡w4=45!

,?072#</$,%*&%!

!

96+='(5) :;*1
%8 >- 43!$#"&.

%tu;³C3nt& *.®
%)

@\

U

&($#

*'

%)

&($#

*'

x¿,,$¦~(+¹h"z¹h

fI

PB¦~(+$¦~)'

¹h

O²

B

¦~(+$¦~)'

¹h

b#°z·

¦~(+$¦~))

¹h

?¥

»

x¿,,$¦~+z¹h"¹h\Áx¿,,$¦~+

z¹h

²ªNP·

x¿,.$¦~(+z¹h"¹hfY{¦~(+$¦~),

¹h

£D

µ­

x¿-($¦~),z¹h"¹h`X¶¦~(+$¦~),

¹h



Se

¦~)$¦~)'z¹h"¹h¦ZB¦~(+$¦~),¹hx¦~)$¦~()

¹h

dª

sB

¦~(-$¦~),z¹h"¹hT¦~)$¦~('

¹h

W

K

¦~(/$¦~),z¹h"¹h¤B¾¦~,$¦~),z¹h"¹h¦^¦~(/$¦~),

¹h

©

m

¦~-$¦~),z¹h"¹h²¬¢¦~(/$¦~),

¹h



re

¦~-$¦~(+

¹h

JÀB¾

¦~)'$¦~))

Gh

¿

¸

¦~0$¦~)'z¹h"¹hE½¦~)'$¦~),

¹h

bj

q¨

¦~0$¦~),¹h"z¹h"¹hR²_¦~)'$¦~),

¹h

´gi¯

¦~('$¦~(+

¹h

f



¦~)'$¦~),

¹h

O

o

¦~('$¦~(+

¹h

a²

^

¦~))$¦~),

¹h

vf

M

¦~()$¦~)'

¹h

y

p¢

¦~))$¦~),

¹h

v

·

¦~()$¦~(+

¹h

«

]

¦~))$¦~),

Gh

?¥

ºc

¦~(+$¦~)'

¹h

±

l|

¦~))$¦~),

Gh

A²

FB

¦~(+$¦~)'

¹h"Gh

bPH
}

９

"#)'(*%&!$! &#(,-+"'*$%¥÷ O ¼7ò3W¦r´í2Øm«PMn40­;ZQ=B!

3Wl]'=B0I¹0Q>!
;GÞÅNà4:<0Q=B!j*Ü4jéIK
EGgb`hHN:*ÿNîLäMF0BHÜ¾õK#NÊK0C[1I¤\ZG0Q>!j*ÜLKXþ4²M±Ý]8º>I019IH"AMðMê5KU
MMqFI=G²MÛòßEI01UM4¤\ZG2
X"AMðMê5KñMqF4©oFßEI019I
H"»MÇD3WM;Q<QKüLUTQ=GÕ
BKö~]=G06&C4$WZG2XQ>!
q1H¬It4J^J^×^H2XQ=G½åõ#jóõKÁ{.ÐÚù]J1ªï=G063I019I4
ê5KxìIKEG2XQ>!AMBTLÁ{.ÐÚù*#+04/!".$2-6(%+0)3 7' ,5&1

|LF0G®6{H@$KK4;Z"UK6ê
5KMâRMK4É;ZYC[1I¹0Q>!®6}.¡Úù]=E3XI½=FF®6M©M.½#ã
×L¨7BH=E3XI=BÁ{.Ð4×S9I]
è=G0YI9[H:<0Q>!

" !*)QBÚùC7HNK6"À³M¾FM£ÒH;ZB¾:æ3Mð"§ÝJûÎ oÜò ¢ !N ÞÝ"§ÝJûÎ ©ò °ú )Ó ÞÝ"¦r´í2Øþ4

F24~%;ZY9ILê5Kè4@WZG0YI
9[H:<0Q>!

oF"(uª 94 <ÞÝ"êµÍt4^tÞôÖ=Ñ8Q=B"©oFßEMðHUáõKF2

{ ¥w AÞÝVX:È¿]0BC5Q=

3WAZ]HËL=E3XIsBÉDYQH®]

B!AMð3Wq*ý?]:Ïz;@G0BC5Q>!

8Gaf%e=G091I019IH"§ÝJûÎNU

''D[^H:<0Q>4",*vÎ"/Y0NÄ-M·'pÛI01l5HN²·ÎUT"9ZWIL
cd_]â^H=E3XIaf%e=G06I9[H:<0Q>!
9MùM¦r´í2ØPMm«]L®64jÔ=GoF]Ã7WZYV1K4^M¾FL

>Y

Lç

=G"r$}@M:øGQB:G]20=B0I¹
EG2XQ>!
9Z]L9M´í4;WL%ö;ZQ>9I]
!0B=Q=G»Mi¶I;@G0BC5Q>!
%+0.( !*",

$

'

!1

4þN¦r´í2Ø4^Æõ¾F''

´íQ?¦r´í2ØLm«;ZQ=B9I]Ô3W2O]Ö=Ñ
8Q>!
4^Æõ¾F ´íN).-(ÿ"ÌL,,ÿL2ØI
=G%ä=GkD*+ÿ=XH:<0Q>!AMðH¦r´í2ØLKWZQ=BI019INþ¯3WM¦rõKü4(u;ZBUMH/[1I¹0Q>!
QBy4®M4^¾FM+9L20G"4^Æõ¾
F´íM}@1]¸ToFÂM:ÙGLVX;%+0.( #&",

4×R"AZ4®6M

'-©M¨ÑL>=G2X"}@1MøGLç=Q=GÔ

4þN"4^Æõ¾F

Q<QK4^¾FL

１
０

>Y

/)
´í&ë*)(ÿM/RJFMC!Japanese Foundation for Multidisciplinary Treatment of Cancer"

POL'K&¹Ë2`óvÀTPá'K01Õ

5"4$èzj%hßU\UBbJ>D!@×"5bP

J":PëN3ç666"/\¸}N,?"UDîZ\ZjXw7Z4[M0"øÊPZjXw7Z4[M3á0að>ê9]Ø0J·Ç0U@!

0"C^aå>JX&VÂ`BIå>JXw0Ùv`aDEÅ"ºû{Bé ° !} yú¤54[3|5/|6âC1K01:KJ@4["Å4[¿2D[@$P\U>D5"yªP¤55+0I3|a>IàX>I>

ÕJ@5"4$1U704M0P5"RìN¦>4GD

X"/U\ud5·Ç0UBbPJ"mcrkE8ð>KÑ0U@!

ê9U@!

FNèzõ5ßU[A"ÅPÆÙtÕ5P×.PZ1

ÒLXP­½¤JQäw"&-5b*)4K(Âÿu'C

No'Z\Xê]`8JQM7]`8J@O!:

P0,hPÞ`\a«2Z1K>I3\U@!+0I^QRìN±>7"FNýJÜPz»þûNKGIQ/

0-N¼8IcË24[QoÎr aWD®¡%P\M;î{EGDKÑ0U@!K:_5¥ÄQ5bPZPÈTjXZGI6D"øÊPZjXZ]Z1NMGI6"C>IÅ¶P/\_NH0IX;^Ãa60

D!Z4]XPa&VÂ`B^R@$Z7Ù]d%g5

I0]K:_J@!
C1>D4J"cË25,,KNS"®¡"C>IâI7]`8J@4["C101¨JÀGI07yæ®

ÙvN¼8I/\M·ôxa60I0]K01ÕJ·¡K01PQRìNù5/60KÑ0U@!ÅIPÆ

Ç0U>I"tÕ5aQ?W§Pq_P3x<2P

ÙtÕ5P|a[0I0IüPña!07<M0K08

ÔYE_1KÝ3>I3\U@!UD´ó:MÕað

M0K01?50D>U>D!

>U@K"ÒÚñQ"# k? ;i ­½¤5Z\+6

þ9z»þûK|>DPJ@5"c@Nz»þûNQ

U>I"cK.¬+IZ\²íJ·Ç0U@!cI3

¦{<BDMK01PaHóJ|>ÂGDK:_J@!

>60I0]_P3aM¯>U>IX"%IP_P·

w0ù5â]:KQx0M0PJ"Å>Qw0ù

g#a¢9]ÕQJ6UBb5"jc n þûYVaâ>"yÜ5Ü<bY*N³0la@]U4~ me þû"Å3|5/\U>DsW xÉ þûA"[ÙB]UT5ba\2I06D0K01K:_J"

Ò54HI3ö|NMGDþû_5D7<b·âJNMÅQÙB]UNM\44GI0]KÑ0U@!Ò´ó

GI3\U@PJÒXïDMÖFJ"=xa>IÍ\PÖFK>IQÆÙtÕ5aÐW"²NÅ`GI0

D0K¿2I3\U@!þû_N34^U>IX"$]_$NQ"U>0ÖFJ@!NaPÿëa)GDÑ

3­Y4N"C>I":PË2aòNÙvY®¡N

0â>4/\UBbPJ"ÒN30IX4Ï0E5/`\U@£f5òVU@Z1N"La3>U>I1^R÷RÏGI0DE6D0K":^Q3á0Z\X3

JQ·Ç0U@5"Ò4[PtÌN.2<BI66U@!

0K01PaÒPáÛK>D0KÑ0U@!cIQ3

cIQL1X3WJK1;=0U@!

WJK1;=0U>D!

(

(

(

1$39?7<@#F+=>&+2
;AE5

B@

(

(

846%*!"%)F?/.(,-C

ÅIQ·D©PÓ\K³`BI7E<0!bLP_$

(

(:

0'

D

µþû4[Q"PGpNH6U>I";ÁaQ"ºû{Bé4[sI<GD_XL:4JË2PÀ

0DE6U>D!

CN`\5/\"::UJsDPQ&·D©'K01*#i%oenpld%fqr

S²5{Qw0KÑ0U@!UDqîP84[bJ+#¾5bÊPO

3[^]:KEKÑ0U@!

,#Study Groups in Japan

Ë2ãPÄ"z»þûP]ÆaYGI3\U>D１１"#)'(*%&!$! %*&$QDQ7Q7327=>;5 L NJ PO./"98CV>;,?<*KZSW#14R*'0:TB41$()%-&(!

SBS7S7/-7;<83
9H K NI QO

V5T2X//U A\ J. QO

K QO(%?1" +)"(!%*'#
EXG2H6 @Y FA M PO+U6,I1$()%-&(!

C[E-F4=] D> L QO
１
２%_P#&'#&6^+(RY!VW\SM@Z:G0 *$),"

JFMC!Japanese Foundation for Multidisciplinary Treatment of Cancer"

E]$ig$:{R-! "%#$!
%87"%26+;$(:9".#-0/#,1#)3<+45&*'!

NO*Yo55s v f_ ig

Fgxb @H=#%nQ!@Hld2
2s t _ ig

D5I e C/Uo5
a0741}` Su cT 

8AkL*&('",s!41^z*s
W MK ig

\3* e?)3 rw,*V.[q; > N,9JoP*&('"41 hj G ig+|\p e ymBX<3
Zs 6~ + ig

１
３

JFMC
,Japanese Foundation for Multidisciplinary Treatment of Cancer-' /0+*,-*.$"!#©yºõCà8_Ï"ÁX§ºõN©y¾NtJ@H"t6ÇõCà.HäÍ=SGJN>Z
MXZ"¼L©±¶^·?BH3DE9T@DNI"6øYB3D@TA!
â¹26Ø131×*+ p
×ê»{¬~ßîét5UNa%e[.ÆÓOK?Þð5$ '¦¡ò1000NmÓ¿ÈÐóÖÌc%f
Õ'/I<G"¯ÎÔÉz^d%bg]%_h`%NÐÅ¾»L4õ1AB7P<A!ÂK·ÇF8VLTW«ëNn´
ORCY\"»{¬~ßNîé#vÁLEK6W.mÓ/LE1G:u½1AB7P<A!
PAÒËNa%e[.
(6\)HO¢KK1AQL&&6\îéI¾ÊkôN/I<G¥­èñ£Í
L4õ1AB7P<A!ÈN×êO"kôNºÝI¶ì[QA¥ôçNvÁH"µÄSÚNß

TVR".6\/5£H<5¢MK1¤ÈIZXG1W@2H=!læH"6\Sxrª®ª"å§ÀôçK
JN¸äH"¸6\HR|¥6qÙLKDG7G1P=!oHO"°L.6\/6jÏãiHÛ±=W9I[y½<"ãi[9;>K1*jÏ[ÑU>K1+æç6.6\îé/NêLKW9I[²s<A³
H"N¥ô¹¼SÒËN.}¨Lí<1ìáôç/L=W©ÃNlà[²s<"wïIÜL.6\H
O¢KK1/æç[3G17P<A!

&)%(' !615+4,7:8.-

2014"29/*0()

5+4,7%:8$#&3;.

À$.,-02-¥/-.
() -1$/,'.,$/,

lÿ­â^u9=A~3â^NY7M@D!½FO8

ÚÕ$èò$W,¬üg%j|½FW,ì½FMúåA[J¯5Y\H9D8"C\oNì"-"[ìLKMVô/N½FJV34S/.'#$34,*)67(!

9rÕâ½FJ@Húå@"`lcilÿ­âW`lc"218100&+-405"%¶

þ${$EÞçä(.HäÍ=SGéMV¾&&¿¢sóÌ)z

il@7M]FH3[!
¤'÷^´wA[ìOìJ-E!¦ÛÈOì
J-8ãÛM(9"'@^ú5[O^Ð@M4AÈ$$î«»çä(Ô#*óóvòÉ,@7,[8"'0=ÈOìJ-N`lcilNª98m

#ch%fkb%dle%ÓÌ):"'0=N4ØWCN!I'^ú5[3Z8Ã]\
H39"¤'÷8Ù×A[!CNX4LÜñ8*`lcilÿ­â+I"'0=N=ñäVNQJGE!
Æ¹M".¡'0=È8.Î!%N/vÁXM¹@H".'/kg NðÑ¨Ö82[J"=\M53¤'
÷Wûâ½F÷8QqM

êA[J34!CNVRO"

Ý¾XCMXZ"ì,N½F(½F)8¨[=JJ"x)XCMXZ³N¸D,½F8$+ ",-')(!& ,*#%)(

êA[=JE!

Ý¾#x)XC^@F7ZJ°FH3<P"rÕâ½
F8

ê@"ÆMª8ÒH:[!¸7:ýSHU[x)O.¡'0=W²¤nØ"½ÅrÛØLKNÊT

J"RE_x)Í8L:-.Nx)Y8-,,kcal(ALÁXËöJ@Hpù?<Y\H3[8"ÁXE<IL,,,A);Y3NàO-M½F8DTZWA3áP/":"'0=S; ")K®}ØNSGMJFHVÑTL

J34!M"-./,,kcal(AáP-IA)Nx)^

/BCJL[!x)>íCNVN8"8_LKNÄ@H3[àO"½FMLZM:3!

NicaML[=JV"@F7ZJ1ÂA[<T82[!

GTZ"RE_7YD:?_A3H3\P"Ýä8

Ô#*óN$î«»çäO"³¸D,N*rÕ

ïÖU\HV=MLZM::L[!
*A:=J+8":

â½F+Núå8"ëß"L9J7Y+W@H`lciÛMóæI2[=JO"=\TIýµ£7YVNY7１５"#)'(*%&!$
LQ9:!

>fáTSb!JUP">fV*_èUy¸+¸TSbUV"i4VuéeK\b¡«>LQ9:!

4_a]&EA"'FJMKLBP!7é>S;H

4°UKV"IAUá=`P?O9b!KTV"$bm7>Ù9DQL!i4Ué>ñs§V1,lP

N9K_èeøFKa",SáUE-e¤;K0pÄATE;"ÐZ·±UqNT_a2K©c«>[a"ña#AæD[>8b!F=F",Sá>®ê

FO<a"!7é>KZa^H9:©qsheUeHarB"6ÌTE;bDQ>8b!Jc>>]N4>E;O9b!

fQ9:y¸L!

!89;%.2&")%:4,+*"0!

>fV¯Ë*UXQNP8a"ªCTHbUVajyU«ðVMW"¯F"²F>fUqm>ÙA

ÜfP"OTP]>fTSbqmV8b!F=F"DSbDQe"iajy¨¢Qi³¨¢UÚd¢cZPTØdcKM¹XÞSR=`"IAU>fUq>.,-/lTØMKqxP`=TFK!

:TV:©ù­>0A±dMO<a"Jc`U:©ù­i4UQ"//+eL*T"ajy«ðU>f°«§Q"J:PS94U>f°«§es§!JUÇ"53p"²F>f>ajy«ðV"¯F>fUqm>-#-#
41p"MW>f>-#0pQÙ=MK!

e;cW>fTSb¥§eC`cbDQ>=MO?K!
KQ;W"Â^?õe/>BbDQP"o>f^M
W>fSRUqmeCbDQ>P?b!K¤PV©¨¢V"ajyQ>f©UTNS>b:©ù

*JaH@+^*^IH@+V">fTSbqmeÙ­e5%HbQQ]T"ajy«ð>^=T>fÉ1e\bDQ>d=MO9b!84¶UKýEe1kg 

öBb_:ÎY=BO9b!

THbDQ>>fT¨N!

ajyUµ>8bQ>fT==a^HASb¦Q.ëPV"*âQeFM=aQb(âe-i

FO×;`cO9bUV"ajy>?ºDHKeU

T/1,g +eQbU>w)+"*^G.zVÖ;

L!²F=`tEcbhqUå£>{HHb\THb+"*<h"ÔhUQa¡@TUHb+Q9

Q"Jce:K\TÙhqÈ)^ IGFI(h:/NU|hq

¢8Yè-)UE>:G"Dc>¯F"²

FSRU}T<Bbô±áUE-eçÆFO">fve<E;O"yqU_9.ëeQ

bDQ>M=L!
¡`Uõ]>fCKUqme+Cb!go&
eQ7V-iT.nZP""7V-nZPe/>BbD

T±HbQ×;`cO9b!
v^c{HT_MO]Ùh

qÈ)V?ºDEcb!v^c{HQ±®U¿9>fPV"¬ì
U~kxr}P>feq)Hbm7>8b!

Q>M=L!
¬A)TN9OV"{oyms&$z(zÃ)>>fUqme+CbDQ^"6Å<_Y7Å¯ihq>¯>fUqme+CbDQ>R`cO
9b!

32%"
#'1+/5--&(0.
ß!'1:9,4786;.)&*$

KWDUTVIAUq>fî>²ZcO9b!»

Y%+øg@:(i:©ù­y¾¢~¦ë

TN9OUu&sPV"­;WKWDe¼:4UÓb
2pT+(Hb!
>fTSbqmV"¼dS94U-#Y'Á:M¨~¨Y)ð%Ýíý@:(ÑäP4>fû¨]íªÊ½äP¦ëY'´|M¨À÷)»FO9b4TQMOV"Â>àMU>fQ
9;b!
c(i2,\`Uij&lnQú2,\`U¿\Uc>)>">fqmeCbDQ]R`c
O9b!
!")%1>=&5<#$!(

3-71>'%/6>fUwÿ]SíªV"*£ª(òþ)+
"*ï
Bíª+"
*¨ª(Õ>fã)+U/NTMEcb!
>fUíªV3FO9b!ü¥Vòþ>>fíªU$, !)'-+*"& #%(.+*

4°U2KV2,VÍUáPP?O9b!JFOJUáUTT8b_èT,>º?O"9,Sá>
１
６

T/T8MK>"ÄlV¨ª^ïBª>3
F">fUó¬^qt&p(y¶)T_MOV¦ZF
9Ò>k\`cO9b!

ÛÏU>fíªUT/QSbl&&wV*û¨]í

JFMC'Japanese Foundation for Multidisciplinary Treatment of Cancer(@)?!z$4HÕ3lR5ª±"±"CÇ¤
±FE2a%dYÙN"7M8MF·@ÁYÖ>éG
ÙN¢X=>·@Y.6D2"¨êF·@Y¸;V>PGüÍDFV!
7TG"C3VUÜKH!àHÆF-·@ÁHxùQÏuYðB-V!>D/J"ytAmG05V#FEHò´ÁHË'"(¹×·@$4G05V?
°×·@"s}@*H$4G05V$°ýé5HìÉF*$.1!0&E"-<WQSUÜGR794"SU·@uH¡-·@Á2xù7WB-V!
2ZÀ}é·@«áI"2ZHÀ}é·@G;VÃÏR"CÇDb%_H¾À#wÒFEYç:B"
»G6941@»H,O·@uYSU<éG¸
;V·@*Y{=;V6DY2²9B~ï9B-V!
"!#$¥

å$âë8ÔÐ'ó/Ð~¿þ"'!0&9-v;¶å(¼¦$núºá*Ìó/Ð~¿þ9-v
q«á*Ì2ZÀ}é·@«áõè NPO *Ì^hceb[\%]fiÎËv

%, +-#/)(r$'º(#ÜBA4U¶«á"íôþ·@v"ó/­&±v"ñ÷Ê%ºL1, 4)-'0,&.%/1"(5A!9;3?=#'0<1B*+%2:7$ A7#%=;!9$#/"-?2157 21>@. &04'+*()¢2412n7%k& ZVpjpj

KRMOLK|S }c`f£v>e`?"1981=by59T¬"w:32a©Il,A57!¢24?"[¤o38_>.D"q<

x>m^"10¨=d1,000§X%kd)o*7E100§X&>pjkI5A57!A7"">pjk=CFpj

/tHGA57!2>pj

`=-+9"3+780A57z­~i@VpjsUW>¥>¡]/v+pj_=?"«#byª>{¦g/JNQP$B«byª>r/JNQP$>uYª;594GA6!
pj

`=-1Fpj

86>@1

3:

68

_-C@

?\h>;-E:6!

<B¬.ltÞ} ß¯òt*ÓÄÿöËkGÝ;V conversion therapy Y2²9>À}é·@*Hxù!

±+À}é·@Y³9>ËæäG05V"!
30ãÂ©+Y:->Ø4Ê9-§ù9Û)*Hxù!Ë ©+GÝ;V5FU&PEGIFNj2b @*D,
Sorafenib @*Hgi`dsû|µ£î®

2Zv71þpÈs^i_%Èsyt loÅÑ½ltÞ}l}"òt}
Ès

Úòt$4

±

Ñ

¥

Dø
１
７

"#)'(*%&!$
"!#$2

$(

*!

&"

!þj·­ñ»&$T3!T4%þr3Ç08@TI<=F;?A"LJEGS?ET9
åð/1¶v«Âdmé¡ÀöêÈâô¼ºáBTD# ³dsje'ÄtÛr3Ç08«ÏÍg´¡378 good quality of life 95./1!
öê4lôVÎ+:BTD#Ïaá\ ÛÁe(ø¢36-/*ÛrMQOT
!

YÐ

YÐ

$(

')

ùÜáòmzE#N$ø¢+:%z[ì`9bð/1¶/*¿Ñ+:

£«4iß(ER@T>H#CÃk378äXÔmÒnfË¼4!
ER@T>H#CÃk×ïÏ3q08Ù)(,-&$.*)(,-&#!"%+'

１
８

¾

ëp

°

æô+:BTD# ¤ýÚe
YÐ

Ìc

¸§

#%

!¹!ßÞûçµàr3Ç08JPEHK#Aåðöê4 S1Wöê
&
ÉUÅ
'¤ýÖ
!

üí

©Ó

Ø{ÕÐ¥YöBTD#z®

ö3,2

378
)Ib2U b tyÿ+:o¢3Ç08 Cisplatin+dose dense Paclitaxe$1 Dose dense TP%!
¨«tdmöê4÷±ÉUÅ Sankai Gynecology Study Group$SGSG%

"!#$3

}

YeÈm xs~ãje


]ë

©õ

ÊÈmYîèzZYmuÝm$½jem%¬|¦Æµ^§úwªÈmá\ _Úe
¯|

²í

hó

JFMC
%Japanese Foundation for Multidisciplinary Treatment of Cancer&$%!
(#
2&&+*4-,13/")%'!
j24z:-AdyYR#8/9'O`92,P(96,7:_:K9t3>YR@
mtf$96,7GXi-38Iv+="10W18~'DYRcjp[BEJ(:gQ@U7Vx2410
9"12W*~"qM1,000F#cjTM)X+4=100F$:YRcjT@rw2<24!
<4"|~;u1s:80?Zk}euhNgQN \{ o mk"nuLSa C HD m

k:1l@^="1b]@,45.<24!

0B%ncade$cfg,hDûa&N2I"Û=do.

NqFJ<\H0S?!»²O":\SIÅu5ÚJI
OL4EB½:w«WýfäÈ­LK_&ï="fä«#nÂÔBÌ­RFL9[JJVM"CPFNë

9L5`ÌcV_"Ý?[BU""V«F_òï?
[:JM=H0S?!
SB"%-+Ë)5`)(bD$¹ûa&5Kõ*,D>MØb?[:J4Y"A\M(75`«Nûa_æ3Ji¢=H¿8?[X8I?!
-4B;0#3+9,:NX1L2"¾/N

!C

ÒO>UJ?[«ÒNYNUO"S?S?,6LVNJLEH3Z"»²!7< -4B;082(=1)( .: 6"¾/Nð5`Ù9Ìc«¾/NqG«áõ%7
ÎM?BZ"q°;iÀ_ì=è9S?!

JVq#N³ñeJ³e_30ì=è9S?!
½²M"¾/Nð5`Ù9Ìc«¾/N»²NS?S?N³F;J"5`NÌc«Nq#Nï;_E

ßUM"PC"«áõ_Ö8Y\BYM)="
ê4Y3Ü0ì=è9[JJVM"ÿ÷Y=0«õzM¤5[:J_*=H0S?!

=H"ÇN3Ü0N°ZJ1=S?!
'''

SB"«É_6>"}5ºN5`Ìc«Nòï
M,6LU_zB=H:Y\B¾/N

ÒNYM)=":Né_3ÓZ=H´7³gì=è9S?!
<H"}5ºM38[nc_ÕZ7O"ãÁ¸hwNï;WncÞN¸>w@MXZ,67Lw=(
8H3ZS?!:NX1L2I"5`Oåk,-Dk]}
5ºNÆO®sN-)lJLEH3Z"5`ôjO"Mªtø)¿è"½V4FÛ[L{.NqFJ·2H
3ZS?!:NBU"´øjAæIO"Kõ).DM¿8

5A8'>@*/$?

&%=B%5`)¿òïP¥~&MG6"5`MX[Æ;ç0BC6S=BpTI?!ÑNJ:]"^B7OÒN¯ãJ"þHN5`ÒW"ANy'N5N¦=Íî"x±:NX1LàM`EH";iÀ?[X1M¯Jc\øNÐNµè_RÄ="5`)¿MÕZ!`LEBN4"HÃL5=H3ZS?!

I6BJ:]I?!AN¨z"YN3e<2V/Z"·2H¬TS?J"ÇJ¼Ì^É4JO4D]NW

5`NÆO_O¯ã¡µIòm=H0S?!=4="I/[:J"SB"Ç54LI/ZS?5?¾/

P¥~5¿8<\H4Y,D5£|="ÒNùí9L

NUr_=H0BJ01

5RN¶L[)vW"âÊ5`"×jNS.LKëB

ú`DS=H"QJ:J30Z=H36B0:JO",

L{.VQY4MLEH6B:J4Y"ëBLP¥~

LÏgL:J_ì=è9[4V=\S@`5"3=0_¿8="»D-©M§8=BJ:]I?!

BC6B0JÃ0S?!

4JÃ^\S?!;iÀM

ëBLP¥~IO"âÊ5`)¿WA7ó+N×j

xOJV/\":N>"Y5-++5`Ù9Ìc

M?[S.RN)v_Û=9MïUH07:JM=H«¾/NqG«áõÒMüP\S=BÉM"ê4Y

0S?!5`«MF0HO"»D-©MöI5¿8=3Ü0ì=è9S?!
１
９"#)'(*%&!$)-,)3_íWGD%3ÿPrOQ"f«ÌN¯$ålPä`¯O¤=W=JQ"ÌÉ÷v4ålns

4®Ô;bJ/a^0K.`W?4"9P^0N¯$O%ig*,P

ÍO.3bJ2`W?4"&Make a

2L_N/ÌN¹Neë=J/DE5D/L¦0[Pchange'3_&Make a difference'UPÃG4,V

K.`W?!WD9P3Oq>N/ì÷eH;AJ/_bJ2`"minor change 3_ major change PÃG

DE5D/L2[/W?!ÝQ"ßL=DIùPÇ

4¶u;bJ2`W?!BP¿L?a[PQ"
&

bOà

;ba9LN6"²OLGJá[¨R=/9zN-ùÏe"^`zTKÑËzOy´+ÄaïP

LQ"#JÉ3¢ºK""+(âKêr·&4ojç'O.aL,V_bJ2`W?!­>fE}±.

%qu3O¯/D÷K?!²r4"/\"EP@$a}ÈK.`"ªO"ÏªùÏOÒ7D$`VX4Ø

4¨TO¥5W=D!9bQ"BPì÷P¿[;a9

dbJ/a^0K.`W?!

LN4_"êr·&P@LN`[ÌK.GD3_EL

óQ"f­¸NÒ2õÉO^aÄzÆçO^`

ñ/W?!Ç³öÀe(ZaDZO"û_PbesGJ_bD consensus PÅe"-zùÏL/0µP[L~Ð;baî"B=J"f5Nì÷e;bDO[Ô_@"OÀ»7P6"zO"C=JÁ/a9LOQ

T6×a9LN6&My research has yet to save anyone'°¹e®/J2`W=D4"ålPÉ÷vP½bDÈ

&Nobel Prize is not a goal, but a new beginning'LÍüO^`"9P Make a difference PµPO&Ïª

GDPÍÂOQ"?4?4=;;1¡>_bW?!WùÏ'e¸ç=J/a9LO"¸PH314$bañ/

D"Û[Y/Ò2ÁOXOaDZPáfÎP~Ð

4=J2`W?!L;=W?PQ"óû=Q{R3_"eA6?Ðe¶;b"¯"û§PÇ³HO^G&Ç³ÿL=JQ"9b_P-zùÏL/1a[PeJ[D_;baK.c0ÑÉ·KP/¹he"ªO"jww>J"9PùÏ°OºZJ¾ÑN[PLÑP«dK

k%vL=J$`VfK/aîOQ¡;A_bW?!

5N/[PLe§7J"._]a§»"Ó1R"}ï

KQIù"Ãã"·"ñX"¹QBbCbOûe¥ZD§ïJ¦z§»"Éz§»"¼Éz§

P¯?e¾=J2`W=D4"¿e¨¶P{O^`»"ÕOQÉÓz§»NM3_"pOLe>Z"borderless þ4kJ="BbCb4ûP­Xe>Z

ÎÂL[=G3`L=DO©I/DÉÕÖH4Ã

a9L4ÞLH`W=D!BbOQBbN`P merit

K.`"DL1"1hu%pK["^`ýO¾ÑNù

[.`W?4"åIP¾=DÌeO.GJQ"9bW

Ï°eWP?a9L4ÃK.a!'LñGJ/W=D!

KZJ9_bDÜP¯?P|PrO.GJQ"J5_DÓP(MO^`_bDÄzÅQ"ºZJ*aDZOÜOÅ_<aeN/5_/4.`W?!ÝK

ÃK.`W?4"9b_PÅQ.6WK[©Uz"

Q"Ü3_P04´7bR9L4>WN/Ì8K?!

zNvquP[PK")§é×O?V5[PK.`W

9PÜe3?PQIùK.`W?!L9c4"Ì8?!4"Ç³ÿQ9be©L=J"^`ÙNl%t

e9`¬GJXW?L"BPIùQºZJ`Æ=J/a%rgmùÏe²ZJP

LÍd<aeWAf!Ü4íZDÌØI°@O^`P{Oö?a[PK.`"

W=J["È"f"§¹QÌGeD^0OÈ

OHN4a[PLñdbW?!Ç³ÿ@SL`Q"6

1D[P4")(DeÃDÝKQ"·"Ï§»O

O:=5e²Z">{e²Z^7N7bRN`WAf!

2/J;1"Ããô4#±4¤e53A"f°@PµnPÇ³9B4"<P

WD"Ò2zOQ"@@P

ÿ QOL eÙZaÏ

ÿ;fL<ØOÒ5

POöÀQ$æË;b"Ç³öÀ[xe/JÚ/"BP/aí³K.`W?!BPDZO"ÜQSD?_­F£

4.`W?!PðQØIeØ0[PKQN6"

Ö"µZÊÉeÈÁ=J¼3NöÀP«\z§eØ/"@SL`PZa

Ü4ú?¯ÒULaeOGJ2`W?!BPHPÓ49Le}ü?V5K.`W?!iO"¬zK"iuO

"©½"½|PÍÂKÌ;ba¯ÒUPBÍ;b4FPEP£tOÙ;?÷N6"Á=6L["m>K.`W?!ÌØI°@]PøQ"fQÌÐzO"W[GO¡YÒ2Ç³OÚ>=J/DE5D/°@LQ~Na[PK.`"û#"ûÊeòL?af

Lñ/W?!

°@K.a9Le¶u=Z_bDK.`W?!
L9c4"ÌäKQÌ°@P¯ÒO>X"Ç³

ÿ;fOc?aáSPÏey´?aÃÿ;fe07aÌ5Pì÷@K.aÀ¯OQªO)§:É=J/a9Le¢1J"9
P5e2!`=J;=48W=D4"êrQJeÈ'G=J/a3OÈ1W?!

J"9Pr3_ Nobel Prize Oo?aÇ³ÿP+Ìe¶:=/IùL":=/øePÄO^GJ"·"

6±X"óPxèL;AJ/DE5W?!.`4L0:

Ç³4ÃãO^GJà</W=D!

¬¤"Ï@PÇ³eyà;ba9LPN/øe4Û[Y6Äa9L4±WbW?!
２
０

JFMC
#Japanese Foundation for Multidisciplinary Treatment of Cancer$$%#!&"

1,#%/.!-$$'"&0)(+,*&2,A52:;3<>9

#

"

n Ø

$



º

¬úöoAm[&mA72yÃ'ÏÉtr ÀÊö:qÕw"ï­}y&÷1}y'Ò

{ ­



¦

Ou»Yööq myÞ"72yCS «¼

M



Ä

aÌömA p6Õw}y Ò

¯ å

¥

&

ö´ööqmy}y«²Õw}y Ò

· (

%

`

ZEömAmyPs"PsÁ[«² ÏÉ

*

µ

Q

>

ùmyöï­mÑË$/DÁ[LdM# «¼

Ç ò



§

®Y:q© m[LdM#"
û®/DLdM# }y"]ÔA }ymÿPs3à¢ÃÃÿ

S

Ú

Î

H

Ou»Yö:q "cð/y BAÿ 

B;24@1247?!3" -5

ö´@YâÝ:LdM# Õw}y BAÿ

#
2_Ø8

!ý

&*()'&7+= 8/.1

"

!

C6%0

%

:õ4B,$E]TbYad¹CX-6£\Á[;ÛY:õ4BÍêw[J938; FOLFOFX6+BV >6< SOX+BV;`dN^w÷)î¾!.A=5;U¤áCWñ4B6?;=ßêYè/D°'kí:õ4B¨ RANKL ¨ô­\HSMFQCX6éø$ÂÙV.xvJ;|4cãÓ×^:õ4BRü[J.A=I^KMXdCX-6Í¡GÒ[J;÷gî¾&ó½ä-]Ô¾'+%ö*@30< CY1%P1l:õ4BÍê DCS ip [J;U¤á9hëá;+
9ÐÁ[#¨á;Üªáöý/DÆ:õ4B¨WQ IL$6bLZM#¨
ôDXP#`#_FR/D[ZORcGOd[J;÷fî]Ô¾

GSK3eì~¶XC¿7mT;CX-60Áácc;ÛÁ[J;|4±ÁC?236)FþIÅçÁ[&IMRT'DXÍêwIÅç[J;Y

ãÓ<34á:.1BUFV#J#]EDX,üw[J;Á[¤z;+RNÈbæ­D³K:õ4BãÓÍû

³K¸?WLJ;|4(Íê"iÖÅ;j２
１

,F|auNP$J! D<#%@?
!=$$0",B43:< 43AC/ &17'+*()
2512k6%i& Y

GQILHGxR ya_dr;cv:V--"25<"Zl46^;+A"n9s;j]"10£:b1,000¢W%~
ib'l(4B100¢W&;mh~iE2>24!25;mh_:*.Cmh^*@={<[f;8*B73!/;mh_:*)6"0})45->24u¦zg=Tmh
pSU;

;\,r)mh^:<"¥#`t¤;w¡e,FKOM$?¥`t¤;o,F

KOM$;qX¤{8261D>3!mh_:*.Cmh^*@={<[f;8*B73!

#"$%1

6>

5.

F

!:ÑÃ\$ªâ<Ý¬â÷þ0EÈ;ö5CªXR IL$6cM[N#ªõEY)[F÷nB nz
Qt"QtÃ\­´ÐË ¹) &a
Q#a#`GS0E\[PSdHPe\K<øgï^ÕÀ*"þ;ö5CÎëx\K:49< FOLFOFX6+BV ?7= SOX+BV <!
aeO_xø*ïÀ!/B>6<V¦âDXò5C7@<>àÌ÷;r Ö}"ð¯z&ø2z'­¾!,%÷+A41= CY1%P1m;ö5CÎë DCS ip \K<+V¦â:iìâ<,

#"$%2

6>

D-

+d³ÃD@347*GÿJÇèÃ\&IMRT'EY!
ÎëxJÇè\K<Z
8E

bÍ÷nB q7Öxz
­¾

N

Æ

únz÷ð¯nÒ"nBÖx0z
­¾

+·

R?

°Z;r«¢n\MeN#"ü°0EMeN# z"^ÕB
zn!Qt4á¤ÅÅ!

äÔÎüµLº@XMK<~5

Éó©

÷¶AZãÞ;MeN# ÖxzCB!

;/2CVGW#K#^FEY-ýx\K<Ã\¦{<,+ëZé0E²(lî;ö5Cª RANKL ªõ¯]ITNGRDY.7!
êù%ÄÚW/ywK<~5,3`Ù9;ö5C-$F^UcZbe»DY.7¥]Ã\<ÜZ!

)(,-&#!"%+'$.*
２
２

§'

9,

)SOÊcç¯E µL;ö5C!
(Îë#j×Ç<k*äÔ=4 5â!

±æ

;2

*GSK3fí¸YDÁ8nU<DY.71Ãâd<ÜÃ\K<~5
!

6>

sÂ

÷¶÷÷rnzz­´Öxz Ó)däÔØ_;ö5CSý\K/B>J_LNYeDY.7Î£HÓ\K<!
øhïÀ&ô¿å.^ÕÀ'

#"$%3

u



P¡v½Z÷;r
CB!

6

"dñ0z

TÛ

ÏI

P¡v½Z÷÷rnz
ß"83zDT ­¾|¯¨®û÷pBn\&nB83zÅ'ÐË

oÙ

¼

JFMC
%Japanese Foundation for Multidisciplinary Treatment of Cancer&$#&'"!(%$%!
)#
3&',+5.-240"*%(!
k25|:-Af{ZQ#8/9'Nb92,O(96,7:a:K9t3>ZQ@

oth$96,7HYj-46Iv+="10X18'EZQekp]CFJ(:iP@V7Wz2410
9"12X*"qM1,000G#ekUM)Y+4=100G$:ZQekU@ry2<24!
};u1s:80?\m~gDlSx [ ! om"BuLRc w T^ om:1n@`="1d_@,45.<24!

1JsiL}+"ÉAq{Az?ºÑ3K;+J]Ì

/?.HnOLÅ4C6!
³~ÒUYLo,JX/?-+;"ÉA]Ì/q{>cL§J8D?B"ªVÁ>YÇ»==E?"ËK8sic½A¡/ÆVp<6!NÂ¾`<B"q{Ê\QA°?z0;"'q{#PÐ£Ï(L¶+84C48!C8"PÐ»[aB"YÇ»AN¶·RSA8DË¢AW¯<6!\?
wJÉ]ÇtL49.I=r4::"ÉA¹?
$'*)%!&"(#!+

yT²È/Mb·Ðsi²AQÄsi

Î98[aAl¬U=u?¤ÑLj1J«<6!
x=E"É/N4;PÐL0HKJPÐ»A_
Î?z0;"GIQ¦A2kÑL-f+6J==E?"®))ZsiÃÅY#®)*Z¨µA^?¼8I"Qv|>JËK8siA©?z08-+L41C6!

84C6!

Ñ·>c½Lg­+É]ÇtAE=<"±E/A~+PÐLN4;

x?"xAyT²È/Mb·Ðsi²

0HK"\?d8J´A¥%+47,&=>9

AT$A2Ã¸LhÀ+84C4;"-+AvÍ=+;+JX/APÐ»B"/Mb·Ðsi²A

84C6!

]ÌLB5DPÐemA2Ñ="8FC@ËK8s
ic½?GI,HK;+C6!¿$"/MÐ?e6２３

$&?3;D,-!*QSk]ÓQlF`c*.R¤]S=:QDak"s
QL4MVZBH!ßÎQT")êSe
Ë

µO³9Þ`ß»3Qm÷aîM¸ýCQ×6HO4

4ZD!¹¬fìRH¶"2v'ZgI`="qvjoyhnml(SßHfá&^OBH/ä}Ss0
Qk"Ã93b>OfUºB"?+Óf&@FHS

ND!GBM"_¼R'*1)-R(*)·*,N"?+ÓQ!,'"*+#&)(_b/ýk"N#Nñ\MO¥BîãïQ&ÂBZ$%

BH!O>d9)êTNS8`ãïR·NSªð?ô4HI:ZBH"L7N?A4ZD!jNT)êQL4M7 ûBö=H4OÖ4ZD!

fÁZa"'*1).R(OªÍBMBZ4ZBH!
GSÀ*0)RA´KM8`"Ä.6k"¯çóo)êT"*0/)RQ©èN'8B"*-#*.ÌÜQ©

n9,'S¹¬Q_a"/ýk"QMãïfBHx

S-QtQÆKH¨NÑëzS6²9PKHÏZf

SO¥%mQ_bO"ØiNT-z·ÀS*1).R+

é4ZBH!GÜTaO¿UcM7a"aTQ¨·+/NQi;PKM4bÚ9e8aZBH!@`Q­`EwOBá9qKM;bOøC"öNHHE[4K:8`)êSãïfæ<HO¥¡à"xSØiNf

M7aZBH!^9M"wBá9½cHSNÑëz9P<ÉBM´fn`8QB"*20,RNj~ÔÙQ#KHÏZfÈBîBZBH!wBáT6c¢¦B"$W

ñSO¥ãïT_¼R'*1)-R(*)·*,NN3bÚ

7~fæ<âKMYB4O¾4ZBH9"aT]æ

ffÇB"òQ@cZBH!|öS_5Q6:4ªN<â`EyJ­aZBH!)êS\>JT>Sf]pfº;bO¤}KM4b>O]3bSND!_KM`:">S_5P1ÕfÛKHSNT{5IO6úìQÆeP<cUP`P4OÖ4ZD!bNñ\M

c¦V"íTf3=ZBH!

/ýk"9ÆecHST"*1-/Rjiwht$u%syGBM)ê9++ÌSÜ"£gOHS~fWH\"®EQö®B"«FIS1ÕSMQ@ÕPaB

Q_bk%rxk"N")êSãïS&Â8`r-)Rf´M8`S>ON3aZBH!

£gfVZBH!)ê9+,ÌSÜQT"ÒX¨°ÊÀQjNæõ@cZBHu]"9gS~{fþdB\SÀfµ4N±BZBH9"+-ÌSÜ\>JT1@FbH\)êS_5Q?!|4HI:H4OÖ4ÕS¨°Q{ùBHS8Ø­4HBZBH!

ZD!jNT(Q7\NO5?A4ZBH!

GSÀS)êND9"/ýk"QL4MV"K$%#!&"

2-#&0/!.$%("'1*),-+'3
0H96@A7BE>

#

"

o 

$


6Ð[yY§Å 6Ð[y&ÿYoyp%
Sü´ ~=

２
４

IA25G1286F"7# 1#
11'.)+('</C =325

"

!

J:%4

%

C&methionine PET&PRM *Q_bSåQ7<b Bevacizumab {hSÝ{VXhSyJFMC!Japanese Foundation for Multidisciplinary Treatment of Cancer"

+

*

ú Ý

,

+

 

_$,Ò3A£?­MJBYsnp&e~o^j[

7

Ì

´

t

e¢8M°G6DÖmð¯Nv_a|&b&N¥y
KRAS `ã6¾Në:ùuL,Ò$ÙyNÄY$[Y­MJB'

Y0ê ë ¤ J A H N Cetuximab*q2w++mFOLFOX R D O CetuximabdM©©©É·÷¦ûð¯© øº

Q k

*q2w+
+mFOLFIRI ¤N¦ûNDèË¶Pë¤Ñ[FBYv_a|&b&NÈf

À

KIF20A JÄÕBY RNA ÄÕSxí¡zymqemN(³°­ëÔTM©ºÉ·*©+¤©Â¢©ÓØ øº

 a

[

¤QN

-

ü34ÜwðMJBY THP'COP'14 ¤N¨M¦ûNDèËä£M©M©©É·K2Ïk© õºñ

W A

w

µ

në3EÅ¯3ð¯MJBY HLA zÕUgïEÅªÜ&MÞä£M©M©©É·Åð¯2Ï© õºñl Qd¸M©©L

Ö0¿4þÐ½MJBYC±`j

.

M¬

$

pNÅH3MJBî>ë¤ª[BYÙy3vð¯MJBYÙýîN´M¬BYÉ·

ÍÊ£>KT¦ûÉ·kl&Ç Åð¯kZ

!

{`m

Y¼[ÈfBY¦ûèËG Å$ð¯k Óå

ZQ=

AD(³¦

cMVYB;(A6ò©]ë¤N¦ûNDèËö^hM©5¿¦©ºì øºÔ »-Ùyu_je[Y­MJBYB+©¤J©î>¤NôAVê

²

9\É·¡ Z



)

û

Á®´óM©© |q¯©ºì øº

ú

*

!

$

!

$

!

$

!

$

!

$ '),(-%.+*&$"!## JFMC"!0. 2,)(&-3+/#*1$'$%-É·O%Stage!(Stage"ÄY­ë:ù§MJB
YôÎø©¤JAHN mFOLFOX6¤Nr3M¬BYÈf)acgymNB3æ~M¬BYß\É·)-ò9±«%0.//#/,0./0#/0-þ§ò9%132§ò9*ÚMò913..§+!%'(&"
/É·O"acgymNjX]L§éÿ*]d&{(]rx^ch&"ü*Ãþ%+J

D¬BYo-M8<Y`ãI¾[RàBY>J9]NèËIB!áç;M DNA ¢8ÛÅ[/£8®

6A"ft}_q¬«¢8*genome'wide association
study ; GWAS+[

6RB!ü*Ãþ%U]d&{(]rx^ch&JD¬BY`ãI¾9g\@ZD"Õ"L'OHP cAMÅÈ×[Ò7>JMV
FHCNje[FBY>J9uMLYDS"L'OHP [6D©¤[@PBYM5DX}#M

L$JLXiRB!0.//s/ÆVX¥âA"0./0s/0ÆRIM132þ§Nò995XRAD!?b­6DE:RAD?ç;N<6LWPMç;o&l|s&i&N?¹¥M¤SH8¨)A!=RB!
２
５"#)'(*%&!$# JFMC#! 9520,6:47'% JFMC#$ 9520,6:47'/Âµ <%£m0KðÜÎÇY÷«³`üX/Âµ38(-(*

1/.+&-)<%Òa±ÄÛf|Kc Stage :D¯X8

8Kc:ÀBT+DKT%TJ(100,YõL

Kc UFT)LV sYõL|$X­K

É

cÂµ

+

*}uLÉX­KcAØLÁV*wf8øUIN7Ü-]îyÁ¹¬d¥ßÅ,/ë*²¬%2012#5-2015#4/ùë*%950ë*/ë*²¬%2011#
1-2012#12eyko 927ë*/ùë*%245ë*+}Ië*#240,+}Ië*#1720

!G 53#9.
2¿xÆÕ,!')*("wÂµZ DKT k'ýXb`bJ@:b"!')*("

2011_1¿`bÂµf£ÚI2_XOQS´îWùfw Â µ Z ã { + ó Ç Y Stage  : D ¯+Ra$Rb ó

FP;NO;S\;b\IN@"2012_12¿xX245

B,X>;SÒaÏvoUÌ=adcùf8úX"YFPf_P\ISùë*fê;NI\IN!

çð?[X8ISwtX>CcðÇqò§sYgñ¯YçðTZmÍ·@7Gdc×Ð"´îW£mãYRT:b^wX>;SÓ_cGdS;cçðùfwÂµXFP;NOA"ÙÜ-Y.'r

UFT)LV ðÇqò§sfÜÎI"MY|$fdYÓÇYfÞYFQY>T"ÃáX}Iù#fo¥ÁVI\K!\NÒaÏvoÛUISxö¾BY

hISFA(X|\<FH;\IN!Ed_pXvR

Circulating tumor cells+CTCs,@Ó¸CzGdS>b"&é DKT l'9hZJ^H,@UFA\IN.

CTCs Ysq''m'UIS CEA mRNA 3If'"Ü-~'x'u'Y¢rY7:WF"Y

0ùX8ISäÜI"UFT)LV sYÉU}ÇU

ànU5J"ÊBÈÿIûD\KUU_X"þBªæ

YÁV_Î;\K!

ÿIûD\K!

wÂµZ"yX`cãrs¼IY/=Ýf®]©å/=X`ceyd¥ßÅUWQS>
b"eykoYPùTZ"ã¹+UFT)$ JFMC#" 9520,6:47'

38(-(*/Âµ <%+ói`!Î$Òa¯ùX8KcTS(1Y^S~s>`[¦^S~sYy;2ßÅ
/ë*²¬%2010#12-2013#3/ùë*%132ë*+}Ië*#120,!')*("

LV 6¿¬S~,Uçð?[¹f"Òa±ÄÛf®
gOè&YÛf;S
{zpGLSt}ivrhY<=¹Yd¥fI\K!í;\IS"WÜ-?aY©å/=X`cãrs@¼IGdcPZ"ã¹Uçð?[¹VPaX_ojI\K`<>°;IS>b\K!
W>"eykoX>;S¡)XìoWù#@ë*GdNâNTwÂµYùPZê;NI\K!

TS(1 XR;S"Ed\TX!Î:c;ZÒa¯T:AWj~v@ïS;\K!9hLW_YZv
{|ßÅTK@"|¤áú"YXe¾Z$YN^S~»4@Ñ\Wù_ôWB:b\Lg!MYN^"TA
cOClÖ@ôWB"¨RÉf6WeW;uZ
ïW;?UYa1T"2010_12¿`bùPf£Ú
I\IN!ùë*²¬f4¿EI2013_3¿x\TY2_4¿¬X132ùYFPf;NOA\IN!
.'rYF¶Y>T"zgù#120f>%Kc
EU@ï\IN!(X|\<FH;\IN!

２
６& JFMC#% 9520,6:47'

1/.+&-)/Âµ<%Stage½D¯ã{+óX8KcðÇq
ò§sUISY mFOLFOX6 s\
N Z XELOX  s X > C c 5(FU º Ë @gÔ>`[lnszYÞMS~²¬X­Kcy;2d¥õßÅ/ë*²¬%2012#8-2015#7JFMC!Japanese Foundation for Multidisciplinary Treatment of Cancer"1óç'%3267ç'*ü@ :90

% JFMC!"31 4/-+'05.2$

4¿xÄ×+,*)&#(%*Dç'ÿ3422+1Â¶8%Stage¾?°ã)ìU5LbéÅr

"')*(#

ë©tSJQV mFOLFOX6 tZStage¾?°*A?<øl°¯\+ã)ìóf

N W XELOX  t U @ E b 5'FU » É B

5õU"éÅrë©tSJQV mFOLFOX6 ZN

gÖ@_Xjkq~xVßIP²

W XELOX tV8¿­PtU5Lb mFOLFOX6­U®Lbw7/c¨îàÃZNW XELOX tV5¿­PtVzg%2²­
U@Ebe"fZw¯]!¤8PVîàÃm

jþÂ¶

&~

1ç'²­%4234#:/~zp&RüÎ<Vw7/àÃVy&vRSÒ¡&J

34¿ZRÁôLbàÃRL!

1óç'%848ç'*4¿xZÄ×+HN=NO=NóVPø·UP=Q§[JNS*Õ6ç'ÿ3422+Gd"XELOX ¸U@=Q<ÞóVhOBÐ=GSB*ÆØ+Bg_{JZJN!4235\;¿3;ZU¥ÓIcNç©HãÂ¶Ø;,74:¢ãÕæPZA`"')*(#-U@=Q"dJFMC63jþÂ¶S concept WVKR"jkq~Ãå*ªå+V-"f§qLbN]Â¶äÝ½êV

xVW>HT¦áõ*hl&`(h{}i£FBùµIcï[IcZJN!
,Â¶äÝ½ê-,Vkr&"xðû¼óø+S/®LbZwýU@EbL+{nê-RV£FaUP=QW"®¹Ý*Y

1J

Û3ºf:ÚLbGSB~HVàÃRL!o|¡&U

Q@aZL!PCZJQW"dÃå*ªå+V-"U®JQW GWAS OERTD whole exome sequence ^¹eb£FUPC"£FáÏfJEJQ=NOEZL_¯]QbIJQ=bSÌ?`cbstf.[ÒeMQ>@±=úJöFZL!

Î=ZL!JFMC63jþÂ¶V6:8SoMbS3243
UTa"ZwýV6?°3222öVLÛ¡&B]UTaZL!jkq~xVo|©Â¶SJ
QW!¤R^Õ6´|V study STaZL!

4-+*)'&1"$#,/!20.(%3
%

JFMC

$

#

&

(

'

$!/16.2035&-,+4
4:55)ìi]6?°¬KU5Lb¬U=©t*WHF t+VÇ"U®LbÂ¶*7/àÃ+
4/4224#5
ç'²­%4222#

nÙ#<StageB(6?°U5LbéÅrë©tSJQV UFT(LV ¼ÈtVãtns&/c¨îàÃ
ç'²­%4227#
32/4229#;58

B(²­%)4229#
5

B(²­%)4234#
;

U®Lb7

B(²­%)4234#
862¬°)ìéÝÎÅVñ«³]÷U5Lb6À<Q*DKT%TJ'100+VîHÇ*~uf5òSJ
N3Ý*Yè}Á¸­c¨àÃ+

$

,MË4

0 yk

nPÊ<

¥m-GéÝÎÅVñ«³]÷U5Lb6À<Q*DKT%TJ'100+VîHÇ)uHÇU®Lb:ÚHÁT)*~uf5òSJN3Ý*Yè}Á¸­c¨àÃ+ç'²­%4233#
3/4234#
34



nÙ#<

ç'²­%4232#
4/4233#
7
64

ü

nÙ#<

6?°éÅVñ«³]÷U5Lb6À<Q*DKT%TJ'100+VîHÇ*~uf5òSJN3Ý
*Yè}Á¸­c¨àÃ+5;jþÂ¶ jþÂ¶%ñ«Câ­fÜfSJQ
ç'²­%422;#
32/4233#
8

íp

nÙ#<

üÎ$Ô^°U5Lb TS'1 9Xt(TS'1.x{otU_b7/àÃ
4/4232#8
ç'²­%4229#

Í q{

B(²­%)4235#
3

v $Ñ

nÙ#<
２
７

"#,(+.%&!$
JFMC

01

*

)

'

-

0

Õ¶8;K/<J HER2 5Ë)IHC3+G=D!IHC2+8> FISH+*É¦#¨úvÅ:KÜÆ@<J^nV]Wid'`RoYQXp$48( %Þ!×µ%
5+.,-."/»Ð$.,--"

æÑ$(.,-/"
/

/

)Ô 1¡

?#­Ìà

$"()!+1*,/#0-/'&%.
/0

gpmq5Ë Stage r!s A!& õBÜ<JNQXlVYq.0º½Õ¶8C/4ËCð)9ÁÞr×µ*»Ð$.,,2"/+.,,3"-.

æÑ$(.,-4"4æÑà)--2: »Ð7*½ '¾}8(B7:Jc\}bojUq-«C/4ËB<Jû9Áµ)¶.Ò¿äáBÜ</1&C- J UFT 8(@ TS&1 8(@Cûð*)ACTS&RC*
0+.,,5"/æÑ$(.,-0"/æÑà)52-: »Ð7*»Ð$.,,2"/3

Stage s)DukesC*á¶.Ò¿:BÜ<J½ '¾}8(@;?CPfTYaqC´êî2B
<JnqZk}Þs×û9Áµ»Ð$.,,4"
5+.,,5"
-.

/3
ÿÊ
/4

/5

á½ ¶.Ò¿:BÜ<J½
w8ªËFCzCâ§»Ð$.,,5"-+.,,5"-.

æÑ$(.,-0"-.

æÑ$(.,-2"-.

æÑ$(.,-0"
2

"ë



|, Î6

æÑà)---: »Ðà³*

Ýá½ CÃ} ùuÇBÜ<JÝàï)DKT$TJ&100*C9Áé¢~)enXhKÜÄ@;=Ú²
Óó¼+ûµ*»Ð$.,,5"-+.,--"2!ë À0»Ð7)-3-: â§à*

pTNM stage räáÅ:BÜ<J·½ßñ8(E UFT'PSK 8(CnqZk}Þs×û9Áµ-+.,--"-.
»Ð$.,,5"Õ üæÑà)-/,2: »Ð7*'¾}8(@;?CPfTYaqî2{ãBHJ HRQOL 7HE
â§$(.,-0"
-.

x @

ìB Âü

æÑà)/42: »Ð7*

Stage r'Stage sá¶.Ò¿:BÜ<J½ '¾}8(@;?C mFOLFOX6 8(Cö3ËB<J
0ð
)JOIN Trial*»Ð$.,-,"--+.,-."/
æÑ$(.,-1"/
æÑà)44.: »Ð7*

Ýå
ò
ìC Ø*

Stage r'Stage sá¶.Ò¿:BÜ<J½ '¾}8(@;?C mFOLFOX6 8(Cö3ËB<J0ð %OQSoen[qCtÖË±ýB<J®è%ÿÊ»Ð$.,--"-+.,-."-.
æÑà)042: »Ð7*

Ýå
ò
ìC Ø*

Ò¿þùÉ¦#¨úvÅ:BÜ<J TS&1C<ôî2(7HEôî2(CnqZk}Þrµ

%Ô ¤Ï

0/
00
02

03

-.+.,-/"/»Ð$.,-,"

æÑ$(.,-0"/æÑà)-/.: »Ð7*¶.Ò¿þùAÉ¦#¨úvÅ:B7:J HER2 Cð %¯%5+.,-."
2»Ð$.,--"

æÑ$©¹Å:í>8I/÷ë @¤æÑà)-022: »Ð7*¨úy°K/<J Stage rÝáBÜ<J UFT'LV 8(C9Áé/4ËB<J
1+.,-1"0»Ð$.,-."

æÑ$(.,.,"
0»Ðà)51,: .,-0'.'.4¬*Stage sá¶.Ò¿:BÜ<J½ '¾}8(@;?C mFOLFOX6 8(G=D XELO68(B7:J 5&FU ¥9L«7HEOQSoen[qC´êî2B<JnqZk}Þs×û9Áµ»Ð$.,-."
4+.,-1"3

æÑ$(.,.-"
3

04

２
８

È
Í¸
Ýå
ò
, £ø

»Ðà)2.2: .,-0'.'.4¬*¨úy°K/<J_MoVR Stage rá9L¶.Ò¿:BÜ<J½ '¾}8(@;?C
mFOLFOX6 8(G=D XELOX 8(C´êî2B<JnqZk}Þs×û9Áµ»Ð$.,-0".+.,-2"
-

È
Í¸
Ýå
ò
, £ø

»Ðà)-,01: .,-0'.'.4¬*Stage sá¶.Ò¿:BÜ<J½ '¾}8(@;?C mFOLFOX6 8(G=D XELOX 8(B7:J 5&FU ¥9L«7HEOQSoen[qC´êî2B<JnqZk}Þs×û9Áµ03ÿÊ ÿÊ»Ð$.,-."
4+.,-3"-çAÙÛ=æÑ$(.,./"-»Ðà)0: .,-0'.'.4¬*

ìC Ø*
Ýå
ò
, £ø

JFMC
'Japanese Foundation for Multidisciplinary Treatment of Cancer($ )%*('&$"!#

JFMC48!1301!C4"ACHIEVE!2 Trial#'()$&$%)B\QX*-  v Ì$âp¢Nó?MZQ`US Stage kÐ<O¦òÀ®üEÈ?M¬ê­rùëD>B
FmFOLFOX6 ùëI@G XELOX ùëF¤×ÚõE?M_cX^rËlÄã~û¯¥ACHIEVE&2 Trial)Adjuvant Chemotherapy for clon cancer with High EVidencE in high&risk
stage 2 *-Éæ¨$|uÉæ¨Ø"ÆîÛÊnéÞuÉæ¨ÊÓø<OVcW%IDEAÑ¼Éæ¨Ø"Æî

ÛÊnéIDEAÑ¼Éæ¨ðáø<OVcW%Ûèq

Ý

ª!|uÃ#Íû¯VcW%

ª!|u
°rÞu

-,+.
IUDHAK2Z0194;75 Stage ?
FR/3!SR S OV/3LYPM^%CurA&
PS 0$1
20J@N#$!"%&'-*'!Standard '"%'#)('!Test '"&'#%->GCT[E"Six months&):=86#<L]*
mFOLFOX-]W
126#7
or
XELOX ]W
.6#7%+>GCT[E"Three months&):=86#<L]*
mFOLFOX-]W-6#7
or
XELOX ]W,6#7eïÖ$âp¢Nó?MZQ`US Stage kÐ<O)ÒÐ8¶é<OJ*¦òÀ®²üNÈ´E"¬ê­rùëD>BF mFOLFOX6'XELOX ùëF4dÚõë)È±$8*EÈ?
M mFOLFOX6'XELOX ùëF1dÚõë)¥$9*Fíè½ÇE;=Mäý»N IDEA,EBÜx¾?M!
f©öçsï$íè½Çgïå²ü¹;LH¥§£
ïå²ü¹$}03.ü+0)$3..ü*Ù ÿ  $0à 0./2à0(0./4à/Ô ¿  $«²üÙÿ5à

,$IDEA)International Duration Evaluationof Adjuvant chemotherapy colon cancer
prospective pooled analysis*G"ßìN
Kºz3AFû¯¥Ta%\C¸ÏF_cX^rËlÄ¥FY%WNÜ
x¾>"µeFïÖN³?M¥C:M!

Å¥$7à 0./2à0(0.01à/htôÕ£Á$ñ0..£ÁiÂîw$0./1à/0/2ß)ÎþwRc[PbcU

Îþ]%a*/*Ë/..y û¯¥·mow )0./1à6/ß*
0*Ë06y ú÷mow

)0./1à7/7ß*

j²üÙÿ{¡$0./2à0(
２９

$&926>,-!*" 4/),'*-.0)$&1(,'+/23%"!#! ,!( -+'&)*"$#%#$
B:25A10517@"C# 0"/?#'.)+('7/= 8214<;%3"?#$-4&$Eoþë@®@D.pè6</84!>A5/+!.D10*7:-C9B@)

0SR>)QD?"p=DË¼?B0Ü¡ÒDN*2;'63)=,(%$&

BøÀT£+F(¹.?/Q@)*3@TÉÙ6ÐãlD½DÕ?Ü¡ÒD{$©#©DÈÅ
÷-ODîD²K÷C=)>mrD4nT):;/J6:!
&pñæÁ'
23#*$

EADÒÍL>)0I/?(Q!
(04&$?E­á?D¦.60"£Ú.íà
úBLDC,E´5B)D?"îT²KQCE

9DØTï7Qé".(P"¸-=~T--B)@îT²KQDEâ6)»Ï?(P"9D$ÿ@6>^agDöx"W%dh%[V^\iYD³¬.(2ORQD?"£ÚTú|C7Q3@.é"?(Q!J:

îD

îT$

,E²JOB)!
J:ðÞ$©NP(¹§CÎ7Q¤ÄG*óÛC=)>mrDN*B4nT):;/J6:!

©v?¿Cß6>£<>)Q3@.é"?(Q!

j}våêEû×?EB0"6:ª&ø.¬AD%'4&*$Ü¡Òc%eb%XHD^\%DÇÔL

0O)£SR>,P9DA*B<>)QD-@)*

ß6>,P"J:"¡Ò]f%ZDåwÂTÌt"3@Tz«7I/;!ª&ø.'1RFÃDÕ?£Sc%eb%XDìçB¾ÝCNP¡Ò©ºõDU

R>ÜÊ?(P"(¹§T¬¥6:ÈÅ÷.¬¥6`%gTE-Q!

:(¹§D9DT6<-PQé".(Q!9D/+)14&$

î±ä·D¯B$ÿE"Æþy

D COI DüÑÝ?(P"E$©#©.qÓTôTÜ¡Ò.6<-PuT´7N*CBRFp=D,°ùCBQD?EB)-!

²6>Îµ7Qé".(Q!9DÎ¢D:KDºõ
@6>ADN*Bòý-OAD0O)î±ä.(<:-ÝD¨%TÖ´6>#6)!
.,4&$

îD£ÚC7Q¨%T

k9Dª&ø.AR;1£SR>)Q-.üÑ?(P"b%_%T´7D.û×?EB0"ÃCÓO8>¬îD,)M,)C0@/CÖ´7I/?(Q!

!7Q3@Tû×@6>£<>)B)D?(RF"sD:KCb%_%T¶):D-ò-OB)!

012)5&.!("#',/-4+.!%"

4+&$3*
３０

JFMC*Japanese Foundation for Multidisciplinary Treatment of Cancer+# P". 35=R-(/@#&%'%&
È«25Ä11y14Ã&Ð' d

RXZUVY[³WQST®r!%'(&"
bµÌª^~E

BbµÌª^

Esv·iOj:H:=!È«25Ä/yD,².t10ÄEÊI-muÅhiOj:=qxAÚÄKM¸1jBCMH:=!

DbµÌª^D:@"Í×¹3LÁÉsgB:@9cO1=>5"<E~"¬ÜÀ¢zw4P±#z°©f¹ »ÕÏ"¬ÜÀ¢_Ó¦Çw §o×f¹ ¿l3LÁÉc
O1=>5H:=!
sv·iAF"Ã3L½µEv`aDk¶E9ÆØOº1@1N­Ósv¾Ò10E´½D9
¯º5"Ù¡|EJµGEÖÎ¾D?1@]{n40MH:=!]{nÂÔD?1@F"euEB
2MA;!½Ã"9¯º5H:=­Ósv¾´½EË$DF"8E¤O2M:@2Û¨:£7H;!
#2@$("=GCI!*+?

%")->0B<H74:A+;5F93,;56/µúß#EÖ@Ü¨ÕE¼Ëþ±0NÊùûI

&"DE1/ ,µEÙ¡|D26N}¥B¼Î

´EM-C¶÷1+O:QDÒ8EM-C6xS% EBM B NBM E³pA%-,;<2J8;!
(Ñ)
sàöÈ\WgoWr183ü7QPM-DCO"
DM=?bcrb1yCP1"ï@E|­¹â°19+AQYL$)F0UD_84AQ^CS >DGZ

æCE0"J;wºÔ°1ëÆACPÁ¤"ICH&GCP D½"¸83F:QD,KE"SDV DMPmhcpr_#Z%eVdf#ÏÃä@E IRB IEÒCB1ëý0'"DE8.

t¨ÕDÒ9PýóFõ,0s)1¥D/4P1TÒ©EÂA¦EÙó*
u5Q0NjWZl%[%L³Ú@FèìEÿ}<A{Û¬§CBS£RC,A"¿1~Ì@2C,ÂAC=?,P!

·vAÏT@"¿S£,éÓCYiq]%S«,`rj%anrkU^c%:M`WH
7<6$)OB!7<NK,S

T][E

S¼8;!:E:Eª±F:E·1º4P5A
ACP1jaXdfS7PA,-ð»1§·D
FC,A,-ÀSK=?,P1ôå"6¼ËE§·ûD>,?FB-,-bcrbS²=?,P0t)1¥D/4P|ùíÄ§EÂA¦EÙó*vÊùûE6Þ(Ñ\D?1@)'v¾îá($)*$ÊÐêç"¿°SwºÔø9PÁ¤F"
Â"! ICH&GCP D½@2PÑÇSÉ.?,P¨Õ#NPO ÝSÍT@øST@,3A,-¢.
:M`WH *\IX6 J?2^,S>V

1;@+P!J;ïFÎØA8?ã×E±DÒ8?¯
ñ-EKE@Fõ,A¢.?,P!¨Õ1¡òÅDz£8?KwºÔø1

æ@+QG"øSH5

ADCPA®-!
３１%)1./2+,!*")*$µ\KN¶vGMêúfÆðÏGNJ3
þNÇG×-ðÏKCF,2@,HÖ.F,]!

ÌaÄ:@*rG+^O¶v8>F,@A3H,-svsaHCF,]!

ÇMÈKH:FNyøKZW,@ðÏayøiG
Íb8>FW,@Ë£H:F÷í8>FW5]0"y"03-(&$'#'"ue(ø1:@ðÏa7Z8>FW,@XMa÷í8!)*$Ðó^GþNðÏK±:FNMJ3J,>FW5]0M)DG"?MßMk%qK@A,F,]MGÚÑXG27¾/³,:@,!

D,FNµ\KNICH&GCPK!»ù:3NTHbIne:@ðÏa×CF×5]H6_1U:,!

")*$yøN9´ÁMè¦øG+\">[1b
/M&ðÏa÷í:F,]@W"Ð,GNX<#)*$&ðÏNµ\KÇKµE,@þNÎºâQK/³,<]6HNJ,!

H:F1WF,3}ÓG+\"ICH&GCP M!»1
U:3"÷íKß:FN¸M{°#SDV JIa·
Y:@ÎºG1WF,2@,HÖ.F,]!

#)*$yøX6MKkCFj1?3"Ðáz¿:F,]ÝUG+]1"îM#F<]ydicfc%tw1älB*1\"&Îºa;Â\K×C$)*$¶vGMêúfÆðÏHþNÇG×-ð
Ï0H,-öKJ:FN"yøGN¯}Mhý6

F,36HKJCF,]MG"I517,ôLC-M
7'¥`²WF7å8>F,@A2@,!

YuMZ¼`a²WF"Ð,<4K<SFaþNÇH,-`5GNJ,1"ÚÑ¶vGMêú

$)*$6^UGµAH&MÎºKÉ`CF2F"ÝfÆðÏ0[þNÇG×-ðÏRH,-}ÓKJ

Ã&ðÏMz¿açW@H6_A1"µAÎºGX

CF,3Hë-!

&ÎºGXy%vM.6aI-O{<]0NÎºK/,FÿJBAHë-!?^N&ðÏK/,%)*$XHXHoqe~"c6Mje{eFX0:\GJ3FXe;G+]HÖ.F,]!

N¶vKN±ÅJ3"¶vNh%K<]0o01MG+\ðÏH±ÅJ,!¶võIPXv2H,%)*$yøNÕ1bàH,-Z\Nìò~\JXM-6HN 3.±ÅGmza_:ðÏa×CF

M6aXCF,2@,HÖ.F,]MG".O

X[-H,-e%raòCF,]!ICH&GCP `K

9%i%HMn%qÎºY=8}M}±:FNlhxd1Ø,K:@6HNJ,1sv%tH:F6-,C@xãKÒ3¯}NydypeH÷íM}Ó61s¡Mµ!HJ]MGI÷Në`LxãGÛCF,@\"Í(NrA1

r=:X!»:F,J3FXZ,!

h\KÒ3¯}1+C@\X<]MG¹KZ:,0J

F,@A5^OHë-!
&)*$´Á7HK¶vKD,FN·Y1+]@W"?
MUGÖ.]HþNÇaËbG&ðÏa×CF

&)*$yøMÐ,M9te|wJIGâQHM

×2@,!?MH¶vGY[9]agJ,ðÏKD,æñMvÙ,NFN¶vÇaËQ«:@*G¶va/6JCF

IaÖ.]H"âQNp¬\cr~zMðÏKD

,2@,!U@ ICH&GCP KD,FNÐáÍbUGN

,F%Hs%{aXCF/6JCF,])1+]1"%\KN!»G2]I5a7.F,]QI¿,MG"ÚÑN1×ÜmM1bM&ðÏRMû\`HÇa:F,3YG+]!ÐR©GN*¦øH

CVKD,F7Íb,@A5^OHë-!

eM

,1"Ðá¨mUMÕ1bà9tJ

HÖ.F,]!
')*$yøMañÞ0K3EKJ:F,@A')*$>Á%i%GNJ,H,-@ZM"U,F,]!ÚÑ ICH&GCP K]:F,3¤[Gî½@j9ÔÁ¾¦KX¢:F,J,U"c6j

XüP\MR©JMG4q$K|bG,5^OHÖ

e{eKD,FNªøMdÓaVï:F,],À

.F,]!

G+]!¶vGMêúfÆðÏHþNÇG×ðÏ0H,C@öKD,FNhKÊU\ñNãCF

()*$yøMàN­~àGNJ,H,-^Mh/[="yøNÐáénÑMgysMv¢¡Sa

ý6Y¦øMñÁKJ<]}2aDÙ\K®:

D5]TE5K+]MG"?MZ-JUGi#+F,0J,H«J§aNG2J,!

３
２

JFMC
(Japanese Foundation for Multidisciplinary Treatment of Cancer)&P\?3102')Ü:-*

H="ÕñPòÂÙ3&s]ÒIJ8ZBLKFP"#$$³Ä×=°DJ¤;]DN8L89\@KQlmq_pfm6L]¡TGS¬ù¯LNIJ8Z

N8!ÏPQäKèDãASELÆÿOúD£ª=>¬=EX^K8Z!

MPW9OÊC[Z<L-ÓO8<OØýDGÓP

¶ÅKQr_vb&e}&L·8ò<`jms]AX[Z<];ZDK>[RL¾:J;Y

xmq_i&sPïëC=uph&l

SDG!¶Å46L=<ZPQt`c{&d&ô

EZmo`LNIJ;Y"ÞO(OÂ.KUG=EZ&6WYU³ùAõVÙ3+]¡TGlmq_pf

L89ñ'K"UDK@«#~{s#Ãð§@=³ù

mK7Y"³Ä6LH@K7[Rr_mda]ó[ZW9ON[Rò?6L=?\IJ?ZLË9!

!

#

!

s1

#

!

#

!

#

!

#

g]DJ3ó

!

! &%'($"!#*!2012WYNHQFCJ$AASLD2012%
2012#11 Boston

Nishikawa K"Chin K"Nashimoto A"et al.
JFMC34'00/1%

JFMC3/'0//0%,Efficacy and safety of trastuzumab and paclitaxel for,Daikenchuto improves functional gastrointestinal dis-

trastuzumab naïve patients with HER2 positive previously

order after hepatic resection in patients with primary

treated metastatic gastric cancer)JFMC45'1102*. -or metastatic liver cancer : a multicenter, randomized,

Miki A"Nishikawa K"Noshiro H"et al.

doubleblind, placebocontrolled phase  trial)JFMC
40'1001*.Hatano E"Kobayashi S"Kaiho T"et al.

.!S85DU[@IFC

2013#2 RO

JFMC33'00/0%+!S22DEBGZMKC 2012#11 TL

k

zla|%
,HER2 Nê¢PÔTÖû.Uß#.Ð©#9PPV®P7Mê-0FO;@Z HER2

JFMC3/'0//0%³ÄPÖû$HER2 Nê#Ä,¢íÝÛÍ¿¸Pá¥1åOúEZü²!*¦)Y¼)DKT$TJ'0//*PUß(¹)wny]úâLDG
÷Íî/ÚH³­5Ñµ*-JFMC33'00/0%

A,FDO;@Z HER2 Nê¢P¶æ.ñº>É´¨R"2÷IW"ãFç/"öJFMC33'00/0KP HER2 ³Ä±BÁ+,!S35D

7>4>:;6VI8><95=]Ç

J"$[à"ìðY»"ö

$SABC2012% 2012#12 San Antonio
JFMC23'/5/0;é%,Increase of serum androgen and its metabolites in/!S113DU[EBFC2013#4 XA

JFMC26'/6/1%

postmenopausal primary breast cancer patients with,ü " ¢ Û ¸ P á   ¥ 1  å O ú E Z ü ² ! *disease progression during neoadjuvant exemestane)DKT$TJ'0//*PUß(¹O

treatment ; JFMC34'0601 TR. -nyúâ÷Íî/ÚH³­5Ñµ$Phase *-

Takada M"Saji S"Honma N"et al.

A-!2013ASCO"GI 2013#1 San FranciscoEZþÈ(³,)w

R"ñ)½øX"\ÎÀ¿"ö

JFMC26'/6/1;é%,ü " ¢ Û ¸ P á   ¥ 1  å O ú E Z ü ² ! *JFMC33'00/0%)DKT$TJ'0//*PUß(¹)wnyúâ÷Íî/,Result of HER2 status in Japanese metastatic gastricÚH³­5Ñµ*(á%Ó]Ì8LDJ(

cancer Prospective cohort study)JFMC44-1101*. -)JFMC26'/6/1;é´¨*３３)*A5>E,-"+gÊ

f!ÆÕ°!ÙÉ}!¨domized, doubleblind, multicenter, placebocontrolled
trial'JFMC39$0902(. *&!2013ASCO

2013#6 Chicago

Matsuhashi N!Maeda K!Kunieda K!et al.

JFMC/0$,2,-Ä#

JFMC/3$,3,.Ä#)Tumor and stromal autophagy is related to endocrine)Clinical pharmacology of daikenchuto for colon cancer

responsiveness in breast cancer tissues.*

patients having colectomy : transit analysis of a ran-

Ueno T!Masuda N!Saji S!et al.

domized, doubleblind, multicenter, placebocontrolled
trial'JFMC39$0902 Additional study(. *JFMC01$--,.#

Yoshimitsu M!Maeda K!Kouda K!et al.

)Multicenter, phase II study of trastuzumab and paclitaxel to treat HER2positive, metastatic gastric cancer
patients naïve to trastuzumab'JFMC45$1102(.*
Iwasa S!Nishikawa K!Miki A!et al.

12!2013ECCO$ESMO% 2013#9 Amsterdam
JFMC//$,1,.#)Phase III trial of treatment duration for oral Uracil'!D1023HLIN52 2013#6 ?Kand Tegafur%Leucovorin adjuvant chemotherapy for

JFMC00$--,-#

results of JFMC33$0502. *)ÉÈAx{¾Rc@58E HER2 ¾rj>ÖÂ

Sadahiro S!Tsuchiya T!Sasaki K!et al.

patients'pts(with stage IIB%III colon cancer : Final

Ò]³Z¢mW@<4=*¦¸T!Ðy!±Ø!¨

13!D513HL7@O52(!IGCC2013 2013#6 Verona

2013#10 9F

JFMC0-$-,,-$C2#)Tolerability study of adjuvant modified FOLFOX6 in

JFMC00$--,-#

curatively resected stage II%III colon cancer'JFMC41$)Significance of fluorescence insitu hybridization in

1001$C2 : JOIN Trial(. *metastatic gastric cancer with HER2 immunohisto-Úµ­!!Y!§!¨

chemistry 0 or 1+ : Prospective cohort study, JFMC44$1101. *JFMC00$--,-#

Tsuburaya A!Chin K!Nashimoto A!et al.

)ÉÈA£Ã½x"{¾Rc@58E HER2 status
Aoº

10!D&3

HLI/C=BO.52 2013#8+¥v7api+Å¶À!±Ø!ÑÉ

JFMC00$--,-*»!¨<G
14!D233416J:82

JFMC/3$,3,.Ä#

2013#11 M;0)¬¯csAV_e½Q@«:E¬n®¹AÖJFMC/3$,3,.5CBÄpi#³uW'KOJLF«>9;©

HPMIGN#)¬n®¹>d QOL _Ò¤¼Ìokb¿\&|q(&V_²XbFÁ>9=&'JFMC/3$,3,.

EBM ?DB@SÔl~uW6DAoº&*¬¯cs

Äpi(
*

@58EÖ³?Î^gÊÍË!¥¶wª×![Çf!ÆÕ°!ÙÉ}!¨

11!ESCP2013 2013#9 Beograd
JFMC/3$,3,.#)Clinical efficacy of daikenchuto for colon cancer patients having colectomy : 1year followup of a ran３４

Ó!¨

JFMC0,$-,,-#HPMIGN#)¬n®¹>d QOL _Ò&|

EBM ?DB@SÔl~uW6DAoº&*`c£
xs@58EÖ³?Î^zÏ¼!¸¶t¡!U·h´!¨JFMC(Japanese Foundation for Multidisciplinary Treatment of Cancer)% ?B-6E,+,98+%!
2=5C.'(@A)1"&#$?515@A7;B646=<4!
(3/)'1+"0$,"*0.")23-&8>%:9#201310m26&' Yq§fqt^csi<u;,0E¨zn8="~©.1000©o<d¤<zn.]17/4bj8"{£h<O$MSQ$KUVPg£;,*7Ad¤¨zn><[.e@CFEB+;:D?14!2010
 JFMC41%1001%C2&JOIN Trial'zn-C="EDC&Electronic Data Capture'JLNTH17d¤¨znH|y17,D?2!3< EDC JLNTHw54O$M}~<|£ln-C"EDC JLN
T<a¦9¥;6*71?14!
¢JVRKIT8="r<v¢W &_ZX'"« &\`'<x^p<A9"O$MSQ$KUVPg£;kGE¡#.~?E"a:ª.pGF?14!

!Electronic Data Capture"*,6(523$
N$S #1-470/.)&'+ EDC@A7

F:40<;*>/

D3>DB?=C/2ef;`*."EDC ;S-,jZTL/H47:9)05M\2h_a;c3%.2QN2G_b&K%.'3*,!68E^2jZTL2A#@2V0A#@XYOi2P[1J(7:96$UgIFEd"
W8]</R83+!
３
５

,By]oMQ%H" \XVW0.(/(#The Breast.2012 ; 21 : 4045)#Int J Clin Oncol. 2013 Oct 8.&Epub ahead of print'

JFMC12&.4./$

JFMC12&.4./$,Relationship between body mass index and preopera-,Evaluating the 21gene assay Recurrence Score® astive treatment response to aromatase inhibitor exeme-

a predictor of clinical response to 24 weeks of neoadju-

stane in postmenopausal patients with primary breast

vant exemestane in estrogen receptorpositive breast

cancer.-cancer.-Takada M"Saji S"Masuda N"et al.

Ueno T"Masuda N"Yamanaka T"et al.

!

#

!

#

!

#

!

#

!

#

!

= 2'?6/&:)@$%#*3.
! YP&'TR *4[KC@OMGA0)+3?ENC@HL1(H!

SZNC@HUDH!
IJC@H$:5#7";68<9%!
C@F>H*BQ,2,<WyºÐ~µIN"­Ô¾¤;SMÍ®

N"~m¬zÌQuCH2VC

LRT"Ç¬/6Ã¼;S*´1²<W/.;Ã°¯Î+

H:TPCE<"Ç¬02Ã¼VFPCH"<WÒ¢

Mn{JCH<WÒ¢~«©NÏ8ECPCE!·NtË;S

½

<WÒ¢

~«©VCH8PD!

~«©JCH"vª

"vOMÂÉª~Ä"~£O8~ozÌ

xÈMAo#AÑ#AÀVTÊÁ9AB8PC
E!@M¦V:TCH:Ó§C¥?PD!

M1VGHP8TPCE<"Ç¬/7Ã¼;S+,290-47(#3.
.9sb:",B6@3g`Ak45*?\lg`uA};*1"Z\79g`a¡A~2?.7
8=>"8+-?¢|g`9~A?.7A715[r0@<13!24:j£X]g`zdpi9"(9\lg`u9};*Ak*<13!248\lg`uxu931<1396"/W0*!

\l};*u(Aem*

Gabriele Calaminusx_^h,BITJ%

vg`u

l





c

h,BITJ% ITJ%

,290-45>4';=<1

8

LCK$PQTGJ%]{tU {tfVw¤]
FOSDR$ERPNGq&ln{t,B]Y$Y'A}¥15@M¼<WyµMAoV¹="¡<

３
６]j%\faih[%^L:>UÑM±©+Wyss¸ ZchXg#Ygeb]ÅVÇ¬03

V¿Ã/02Â'05Â(/3Â|)L»GHq<Ol#£Ö8ECPCE!
*¨rMÒ¢U@J<I=PCE!

~#`gk~M_%dJC"ÂÉw¶M¡<WÐ
~JzÆK}ÕV8"³=K¬pV¥?

JFMC!Japanese Foundation for Multidisciplinary Treatment of Cancer"

ï@"íÞ¾å|TFMÞ«PBM\ÉâIÓ9!
,¿.,ME¯Ü4íÞ´à^_g@"ú6é§´çIf9@"íÞ¾å|MÒÖ±JÀ¬LF5GÂÊ^Î5"íÞ´àLG(Germ Cell Tumors&GCT'in Childhood and Adolescence the MAKEIExperience)LF5GÏ^Î]\U@C!
-¿/M"¯DWs4íÞukl$^_g!©'U

>If9@"¯DWs4Mo^>ï5CD5CÈ"íÞ´àÕ,´çIíÞh·LåMö7#ßu^LF5G"Â1+=.).C"@/?;B>#AD97308FE:52&(!'<-$%4*,¿-/MýC¹ÍG<!,¿-0M%-2M¼4

Ê^Î5"BMÈ­X1øë

F8´àHÏ^Î]\U@C!
-¿1MN"ª@QZM4$IKZU@C:"E

Y&E¯DóQ='MbíÞÇ»å|wîÛÃ¯4(.Ð:_À¬ÒÖ(tù÷)£VÀ¬Y(Childf}$v.LØ?\",¿-1MLÏ!

i#"ÔPKN´ç"Är|dKNì´^_ghood cancer : rising to the global challenge)"(The@"ÒÖ~x}HM:_l`(tÌ;MRüLF

German Society of Pediatric Oncology and Hema-

5GÄì´9Y#d^æ<U@C!UC"J´à

tology&GPOH')"(The University Hospital of andHãZ+_H®Y\["(:_^f$s}w}j

the Department of Pediatric Hematology and On-`icmLA[CVMþ×AÆ)LF5GÂÊ

cology in Münster, Germany)LF5G"MbíÞ^Î5U@C!

Ç»å|wîÛÃf}$v.L85G{?\"

?YL"JM:_ÀjdT^_g@"a':Î

è8XPqboMíÞ:_À¬MÅò"8XP]:û2¡yÐ&Unio Internationalis Contra Can-ÒMíÞ:_f}$vIM±JÀ¬MRüLF5

crum : International Union Against Cancer'qÝ>

GOôKHz:ÎK]\U@C!

Lf9@"UICC IíÞ:_ÑZIM²vLF5,¿-3M&nÁ:_kl$p_!íÞ¾å|GO5pajenh{:ÎK]\U@C!4$H

MÒÖ±JÀ¬LF5GÂÊ^ÎECT9"&YMÊ?¥:yt@U@C:"jgiz$}^nÁ:_kl$ê9LGÏ!5Nñ¨L"

l@?Z=K?\Clu?N"?A:ÒÖM

(Germ Cell Tumors&GCT'in Childhood and Ado->"I56³xKð^m7G;\U@C!

lescence the MAKEIExperience):]ZU@
C!

-¿2M"Gabriele ?_N"ýC9YqboR¦
Ò?\U@C!

&E¯D3E¸,¿-4M(:_MÚ°^ä[))/µ,*.*,-'_g!ÙË]qÝ>"!'Ýc¶>I-¿,0MM(ÒÖíÞ:_MM)LF5G"
íÞ:_M-¤ö7^0ACVMºSI^*û
HBAS;ÂÊ^Î5"ICCCPO&International Confederation of Childhood Cancer Parent
Organization"ÒÖíÞ:_õMye'I SIOP
8XP SIOP

Asia IMy½LF5GÂÊ:Î

K]\C=IN"íÞ:_õMLIEGW4[¢
O@5=IH@C!
,¿.+M"&nÁ=JWT^_g!¾å|#bkr%ÿ:íÞ¾å|MßuMáÖ^>@/),6,=.$%4*３７

(?mUc}DE#A
15<('FHC97?G:>8
w246O'5M(%:7,/("`i6%:7.?1,/!

2@A97?#.)"+!/*,0-$4D6I>8)5hZ6"jl\Xi>(?q\X4dQ+.

S\X5vs>u;2284"p=(_5S\X5T23;tb>Jw-;)2>2,0Re+<7,/!yn,7,/(")5hZ6w19'9R
e+<"w246$5jl\Xi>`&/,7,/!w244`+</jl\Xi'95x>[a&/,7,/51*N+&!
k\Xi

$

L~ 

@A97?'E

o{WV

F@BGC

YIPgP|U|UK IgUz^\XP]r Hf

YIPgP|U IgUz^\XP

&'%

;B

3=

:UXÌ_óöS±å>F7F2P@!¸ÆM
ATL LéCJÌ_J=H>F"O~LCZûECqpfiltbÚæ»K_JLbâÇ¬KÁ=AF)7P>C!;LÌ_JMô!GU4>CÑX<ÍíLÚæ»KK HTLV$1 Tax 5w,»Käò0»K%CTL&L_nh#pqpfi
Z->"BXZPCÑXL!7KR>².TL

N² HTLV$1 °ZûECÌ_JG@!ÆMÚ
æ»K/Wú¯GLO~2Lõ"ÔK HTLV$1
Tax 5w, CTL L;AZ%1>P>C!PCÌ_ZØ9C¯LO~2LõMÐ¼KÌ_K1
CUXF2WbâLøôIKSo\#ikga=
X"bâ¦Z÷N@W>'¾^L{DKJVP>
C!=UKM³Zà5AF2CD2F2W®½GM
bâÇ¬6ÜYV"$/ýbâÌ¬O±9FLß@6îRUXF4V"¸¯Ð¼LÌ_JH>FL"6¶PEF7F2P@!;LT3KÑXLÞJÆMFó+,9.'ÓÖªÑzóYÊ¡(L{©!ZÂY>FLªMËK§L´À68>8"

H>F"£Û6[due#}(*LøôL\2W:Q;HS1VP>C6ÑXK­=XWª6

6[bâª?LE%ªÑG1Wì6Pë[Ù

G7F`5ECHÃEF4VP@!¸¯MbâÇ¬%0yÉ##|yÉþ·ªO~Ì

K@WªD9GJ8"¸J4N=XF2J_ES&L"'óï0»K<¨B%ATL&L¹

2"ATL ÑXK«UXWO~ZñáLNK

ÌZQÄ>C»K_JL]4TN HTLV$1 ZñSÕVü[G27C2HÃ2P@!

s`jcrLN(K@WªK¥YVP>C!
ATL Mmh0»K<¨B^]tb*¤%HTLV$

３８º¯KJVP>C6ªZµ3K1CV<ðaÈ
VP>Cì6P

ÙZM?RO~Ì_ÎL

1&ùÑLT-)LI6=ã>"_J+²ò

X"3ªLøôI"B>F<ÅZ2CD7P

LV¯6#Hv2ÏG@!¢9MÌ_JH>F3>C6[Ý,Ì_ª¿&LXKèTVÒê×ÿ¨»KxçGNK² CCR4 ²!_JJI6>å:P@!

JFMC&Japanese Foundation for Multidisciplinary Treatment of Cancer'$)'+%-&1,(
4BdC"[~B[PK¼8I¨KnbV>7<z½7"2LÀnbdBnbKV8Id·@69I4>@GH"§ZnbB@8I4>Kº¢>7<Y6JE7:!²23­¥C-¸BnbVKz½7E7:2"sÂ©X[nb³g}p@GH"²24¥C,¸BnbVKz½8I4>>?HE7:!²24­¥@z½6J:nbVCB>0H=8!E:"q|"nbV>7<5\»6J</InbVBq=BFj{/:7E7:B="5Rª/:;3JDt/=8!
¬nb

_^

(

T ¡µ

)

¹Ã `®

*

aW rÁ

¦¶[[S Q[knbX

+

¿ R

c¤[ ]muX[,£¾o2LMON#$nb%h2LMON# lU«Xw£

¯[[S ]xX[nbXf)'+%-#.

nbV

´

° 


i

e v±
y£.1A

h2LMON# lU«X

"#!

*/

0

ÍP"¶éc0ÝO7_`Û­¦Î¨)èã0Ã
Hç8«>'ATL(O¿Ð^RË?DÃH^GO
\5YRCO HTLV%1 XærcmfqOPM@\­¦*O­¦úI"7_Ø*Ð^ÆüOÎ¨I1\­¦ÌÓMÂV>]U?D!±ÅW"­¦;;%I1FD¼\>¤¹©×7_gwi$« 3@%

!&IîéO=Ë2OWJ"Cì@\`Û­¦gwi$MH­¦OÌ1^?H5[U@!
ATL Pxç8«>O-ÖI1[U@7"BÉéAOâEW1["ujvbate HTLV%1 MY
FH8¥<>]\ïÜOªøEJ:[U?

ÓX HLA @?+»ÓLK"|ß+ÓO

D!UD"©×"csp¢X`oscO¼#M

ùP"ATL ¿Ð^JVÓ>UMJFHÙWL{ÔM,?H2\<J7S.,7ðM:["z³ï"G:I@?"}^îâ¼J?H5L7å^s$

KQOU#LFG7JZ]U?D!?6?"ï³

k?H29­¦JÊFH5[U@!

9Ü@\ÓPOÜ´ïÓO/+)-I1["9L­¦O]]IP"«Ó HLA #kl$6

Ü?L2F#O6þP'9"UD"ãO|1O·~

ZO|ßÐ^O\6ZÈU["½änwd^V

MYFH>O¿íPNE¾4I@!-9Ü?

?D=«|ßh$eOyòç^Ñ?"±ÅPe÷

H?U3J"«ÒI@OIÕÚPI8UB«kl$6ZO HLA @?#h$eW¡V|ß_?"¸7_ÄÐ^MP(¸çI"/7éô[WGOµ^ê?"Ð^G+ÓOd^·;DÐ

OO4>I?D!

¯^?H5[U@!

|ßÐ^7<O-/7"$#Jñ>]èë^Þ;­¦IOÍP"Á9X GvHD ÏOáýMWTV

H5["|ß+ÓM²FHP#O­¦èI

L¬öO Donor&Recipient À»[êJ¬öò<O?6?"
P/7éô[^.,+)-M?Þ;U?D!

bYXZ^û.?H5[U@!åÿIO|ßATL IP|ß+O°?2ó7£O9Ü7TJ_

GXCOõOÇàLÐ^GOþ®/Wí4AD§B

KI@?"ºaÓSOyòL|ßGO9JMçÒ

NQY[_2Ð^GSOZPI8UB_OI"

３９"#)'(*%&!$¼BG»jM¼ljGÁ³H×.zCE?A

?A1PJ<!

1PJ<!

F"T3Ø}wZ_[%GÃbÍ7/H

Ú¯{BGa¤ÊHJ>Ö|¨LE.B<

kÕGn°B<!nÒGe4pU~RQ

3"·²ÂM GvHD L¡Pg0A"Ì}wBL

N/F"½$¥Ud4µKAmº;A1PJ<!±ÐO2FEP@@-PJ< ATL ÑfUKA

GÉFH"¿u²FH¶ÅÓE£ÈU´4"J="HTLV&1 UÔ©B4QN/F"®¨GÉ3EORÇEDFT=QÎU;A´4"HmºF

QUq?A1PJ<!Ì}wBa¤ÖU9R=«¥<Q3ÕJ;=!Ä¢FG

ATL nBH"+*À`?=C?A1PJ<!-P3C/8:.J;=!

!

Gª­U,Ï¨0QF

#

!

#

!

#

!

#

!

#

."mº>

!

* )F:+?"2AF% ),3!./+2567#40%'1'-"40%(1&-$!%$"s&cbvNYLZy

gMbvNYLZy(36B3bvNYLZyNYLZ5>By(?C,F:'=C"atoSLZy

jr_vNYLZy*"1)NYLZy;C37D!<)@"4NYLZyNYLZ*3("D*Dy
Q|kW.CFNYLZy!#$"

NYLZ/E8yfh

NYLZ0)9"C"-D/*37y

ThOdXyPxy

IuPbvNYLZy
G{p`z^L#U\K]$

eigJlHyejr[wbvNYLZy
nhvmVRNYLZy
eqvmVRNYLZy)8sÆUtË9RQrx"§GÉvIj
cC;Ai¾UtË9RQrx"§GÉH"¸± HP'http://www.jfmc.or.jp(FVXZY
5>9.!¦¹oyÙ3\W_^%]B
4J<!h¬NS;51q.¦; 6J<!

ご厚志ありがとうございました
４
０

JFMC
"Japanese Foundation for Multidisciplinary Treatment of Cancer#) 8;42/-&?$+(7<-&6$
4X±xÍ©ðÇG"*4X|­Eæ;/©ðß+Wwï=T?MFô¶¤W08BW®DáB;"4X|­:XI9rÁFÛoF?ME>FãzWt?;@P68BW2äÀ/?;K=!

"'15:,>)$9@=#+.3*)0%!
4X|­Eæ;/©ðßBG"®E|­:XF QOL(Quality of Life)Wæ¼E1?i½Ai¹A5TîÍD©ðßA=!®DÞßB;@¨FQ0DÒêWËj;@/K=!
9c>ADvp%'$(Xr0'C1c>/5&©ðEªÜF¦4ÂA5èsWy;MK=&
入院より外来での治療;s?vp2qh0tM)#&$!Ý°:U?âmÙ{(c[ba'd"Ze\_h"eh_`h)A|­:XFâmÔW{ºpA5U
H"ÚìNµD6"©ðtF¾4ÄA5TÕ !?
&%!ÆÅò
治療効果に遜色がなければ、抗がん剤は高用量よÏéBµòÜ
り低用量での治療
zÏé$Ñ<©ðtDRÚì4µD/ÊìòFÞ
4yAG%>F?MEG"uë3RFæ;:4×íA.S"ÐÇF:bFT`fd)5HNO*8R31mPô¶¤A FOLFOX ðß(-Ó}F§ÂÎÌ)3R"
4X(SOX$Y\gh"ZELOX$]f'^DC)Ñ<©ðtD
点滴より経口投与による治療
R"È¬QSlLåFÞ4y4XFçv¦·(Úì)Ã
F²«<ZKn[vp1guFE-3}Añ/3N%=Z_ADoV^vp»³ÖkW´:6A5UH"¿OÔ¸vWA5T&»³ØÔ~AN
術前補助療法の併用により腫瘍の減量を図り、臓器・機能を温存できる低侵襲手術の開発を目指した治療pxðßE,»³qÔE$½©

á#ãzBuëFæ;:4«;@*4X|­:XJ

F¡/OS+4«FNFBDSK=!>8A"à¯£E9ÑÉ7TuëÞF.??3/9¢n#9óW¥VU

UH/A=!

*8YDeUvJGSa2"l]25k4I1i46Q1jB7W+-L@Sap\.,!
(2]:+0D.D7@-l136-E>4!
(}gy<9]`85+6:spo9awz/,1DGFb/*E>4!
(]k-C;hnWS8:"}gy/\d4F&/ImZgyNQ#L'"&/Ij9*B?'$Rc^nq9c^em%H-136+>4!

(}gy:":X.D:V>79xZAT8-+6&/Ij'9fvu7[{9tr7Y9-85=0$OMKJMPiU~%2_|+6-E>4!
４１"#)'(*%&!$s¬â0Òp£LÕæ<]C&õàzPzÿL?\Ú'`«1C=T?!

75/2-/8,0+.14!
+ zrI0\âßM{®4NzrI0\ÒM¶1"

$9 è%
6"3 ;MÚN" s¬â0Ò6aÂè¹D¬â
$lw&3¬â'J12!
%æá//ÎMæLG73¬
âMzrMõàzPzÿL =!@K·¤`æV"zr
MämMkæJ;]Lú2zÿÁõM*LYEH"3¬âM¬6ýMC`Ó\;J`9èJ?\!

½=8N*©}±MÐû`À9CJ7!
, zrLF7È7M60ECJ7!
- zr5ZàzMn²"º60ECJ7, zr6àz=CÌ¦"zr7-MêF`5Ê?\!;MÌ
¦L41H"zr6Lø#=CzÿN;]`(=K1!

$zrM¿&%$È 7%

6#3 zrN¯ÇzrJ="¯ÇzrN¸M¥M1@]

6*3 zr6"¸M1@]5L~ì?\J7N"A·zM

5L~ì?\Ò4NâßJ?\!

LY[È7?\;J6I7\!

!
+ âßzr 3¬âM·L¯î=HêF=Câß!
+ 3¬âMæBMÞMÚLqü=CJ7!

!
, Òzr 3¬âM·L¯î=HêF=CÒ!
, 3¬âM7<`ÉF9"4N9èLü?\£o`=CJ7!

$êF¾Ü%!
- ÖìKA:K8zÿ`øõA@"´$1M@Lv>

6$3 zrLK^2J?\Ò4NâßN"3¬âÅæMêFÑ¨Æ$>»+%`çÄ=K9]OKZK1!
, êFMyþNA·zM`Hæ?\!

K5ECJ7!
!
. BMÞ"zrJ=HQ<_=8K1JöVZ]\£o`=CJ7!
, zr`È7L?\J7N"È7`Ð?\A·zL41$A·zRM.§%H"ì~zrL)8Mz`;3K9]OKZK1!

6%3 A·åN"A·zL¯ÇzrMêFÏ`.§=K
9]OKZK1!

$zrMðé%6"!3 zrN"&LæV\ s¬â0Ò6aÂè¹D$zr7-%¬â¯Çzr,Â@¤LÃ1"ðé`À?\;J6

6&3 3¬âMzr7-M>»P«·¤N>»,LY

I7\!

\WMJ?\!
, ¯ÇzrN«·¤L'¢6×>CÌ¦LNÛX5L'¢ñ`3¬âLçÄ?\WMJ="'¢ñM>»P«·¤N>»-LY\WMJ?\!

$Í.M }%
6""3 3¬âN"¯ÇzrL =Hã[ïCÒÍ.`"lwM¥MÌ¦LNá­¼R}º"çI7\WMJ?
\!

$z ÿ%

!
+ ì~ÒMîn60\Ì¦!

6'3 zÿN"¸L:\J;^LY\!
÷zÿN"zrM¿&Lv>H"¸M%LY\!
!
+ âß +¡ ,**"***t!
, Ò +¡!
, ªûÅMEÏLG7}º`VZ]CÌ¦!
!
- Ùó¥MS5"ÒÍ.M*L ?\0BPBM
ÞM0ELG8Ì¦!

+*"
***t

, zrN"2?\¡ÔM÷zÿ`3¬â³æM/0LY$ÚM|æ%6"#3 ;MÚM|ùN"A·zM`Hæ?\!

[øõ=K9]OKZK1!
$zÿíM°ë%$+ Ú%

6(3 ÙÎMzÿM2D/*(lËNæá.ÎLæV\6"$3 ;MÚLæV\WMMS5"!@K·¤NA·s9è·ÿL?1K9]OKZK1!

9 4$àzM·:%
6)3 zrN"¸M1@]5L~ì?\J7Nàz?\W
MJ?\!

)K4"#P¯ÇzÿLå6&LæV\!

;MÚN" s¬â0Ò6aÂè¹D¬âØCMêMô5Zµ£?\!

?\ò=PÑ=¨UíLF7T=HN"ì¬âg#hf#c&#´uM41'

L«<]H4["Ñ¨ÆWdbji#eI7T?MI"xÝY^=841Ñ=Ë:T?!
４
２

JFMC
!Japanese Foundation for Multidisciplinary Treatment of Cancer"@5"nªup?g¨=<7*8>"do=:+H93!

+?.&3<A#!@950&74'³w®g=±($!*>/,8:6-L=i²<k3IvqKc§,G«2"
z="uKy2.8*@3!
u<7*8>³w:28f¥;³vq
K¯28{28*@3!
@5"c§vq<{0J5vqW$^-¦28"}=r¢vq%JFMC vq&:280JI/:C)H@3!
'<FIc§vq¦©g#=±('­t9=³wX$U±('ig¦©<~25]SU$('=vq£°
K@:B5-L²=)
EA=¦x('emlQb]R`M_ ASCOGI%Pb\abQSO&
9=¦©=±(%!2;()"'&=1¬¤ch"}=x6
50@1@;
Y[VNS

sj¡D
K|45}

Z`$TK¦x28*
@3!

４
３

&':39;+0")%2;"571:*$84-9$.,$<#30'+6*)$/(&!
"+'$&(#
&"%24

6(;7>

D=1532538

5)9I24

A?07>

D=2943719

'#$24

@/+1E

D=0373939

5B@/ UFJ 24 6(;7>D=0663141"%)*!.-,#$136#0071 =5<8=6471#28#6 *+,1%2)#*02.!"-%1,4(&*0

+3'

/3$

TEL!03#5627#7593 FAX!03#5627#7595 E-mail!jfmc@jfmc.or.jp."/-"(!http://www.jfmc.or.jp

!

"

!

"

!

"

!

"

!

"

!

! /(16=4$%3)72@-+16 ?'!:*'!&'><";52694,18.0#

H

*

,<
) * 0<,4/#<ATPÓ.&6PÒ

J8<
  §

ü

[òÈS&6c¢

:FJ8
ý × µ

£

D:õÈSSÒ

J8

Â - #

ï

º=\áìHHÒ

i - åkãÈSÈSHìÆÁ ROS$ÉGRO%c¢

 w

4

C¼DOÈSDSôc¢

 - }

â

í«DOÈSROSÉ&c¢

ã ® ¥

ï

hÿÈSÈSH·'OSn_ô¬NZROSc¢

ø ¼ }

¸

È9ÈSÈSHDSn_O¡>ROc¢

ø Õ y

G

þDOÈS¬NZ"Á !ß½"ÜöçROSc¢ x±þDPt+" Ü å|ØQÈSîÃìHÿôÿôÒó Ù ÔG<yJÊû²'(n1(ìH&6HÒ, Õ²

yJÊû²'(n_P1(ìHìHÒ

 ÿ ©

G

y9Sa¿ ØQÏLìHìHÒ

 E 



Ø`ÈSDOSn_ªD:*7:#1=A³±Úàc¢

¾ r Y

ê

g¤ÈSÈSH¬NZ"Á RO$ÉÝRO%c¢

« ÿ p

G

0->.@#8?;#?5)A.TPÇëÓ.PÒÙ Õ@

ÑÞ·'úqÀuPt+

« ÿ ©

ï

Ø`D:2A3#&6HÒ

X è ?G<GæÊû²ÞÿÄsbP8Ò

 d 7

â

deTPPÒ« ÿ~+?9#TPÇëÓ.PÒm CEO

V * G

´

D:õÈSØ`%ª¯%8ÿ Õ !2éÛä°÷Ø`ÿù¦fPú­ôÒ

v Ù Ð

¨

Þÿ¹/{ebP8Ò

-8
Î Õ ]

5

363Å§OSn_ªªÒ

 W ^

G

`ÖñÍFD:K2A3#2A3#Ò

C
M
４
４

¶

;

.

zÈSSÒ

*

3

G

E z

l

Ez-UìH8Ò

Õ z A

Ë

ÈÈS&6c¢» Õ jMÈS&6c¢ð I 3$BÌo'(2A3#&6ÁÒ

JFMC!Japanese Foundation for Multidisciplinary Treatment of Cancer"

ML(*.
(*D

N;95=8(*.
(*D

ö ø w

g

d4éYéYC>Yx}kP>Yx[U$­T>Y;Ln²

ÑÂðéYÒG[U}k»»õé o MYAÌÓ\YHÓ\1;267.&éYYõ
^

ül>Y>|éY8Yõ$>YETYPõ

(*

 D ¹

A

WYmáüUòJ/C/CõOòJéYUY7Ì_ãUYPÒ:ýzY}k«n²

u L *



v)éYéYC/èãXPY'êAXP(n²

 L 

(

0¿>PéYXPYê)n²

(*

Ö I
¼ û â
¼ Ô 1

`ÔéY>|>YY78Yõ$Y7õ

%I  ¾_éY>Y7#PY±b#PY7Kn²

ò û e

d

GíAÌ*-}kT5ç*-}NH/CJ` L[ªT­LSI95/0<2òJ:8:6;&^U®

ó LÂðéYFQn²0 ø îj)ülUPéYY7n²

= Ù 

Ó

é¡WéYéYC>Y}kP±bXPn²

È ø ð

¦

lúéYéYC>Y}kP>YýzÒ:Å?Yn²

 þ c)F43A7(*.

Õ

(*D
¼ Ù ÿ

O

N;43KG=8(*.

¡WWö/Cãõ

(*

(*

B û Î

³

>Y9¥éYYõ°Z

ä

qëéY5ç/CØì>YV,3<4&!&n²

 D ¹

A

WYmáüUòJ/C/Cõ

 ò ñ

¸

"WÎAÌW*-}k3<4&Ò:ýz7K7Kõ

%I Ä O*-$]ÛÁ3<4&úWs/CFQCõ= L É

lúéYéYC>Y}kP@¬Ü±bY$\

6,'B@H+(*.

RæKS©YYn²
peéY>Y7Â7ÀN^XP!&n²(*D

6 þ ÷A^È Q

R

GíAÌ*-}NH/CFQCõ

= Ù 

Ð

³

ééYéYC>Yx}kPÀNcXPYn²

(*

ù g ä

H

üléY>Y7±bXP${^XPn²

1:!2-(*.
(*D
h L +

Ó

é¡WéYéYC>Y}kP±bXPn²

é o M

O

òJéYUY7Ì_ãUYPÒ:ýzY}k«n²

 L 

(

0¿>PéYXPYê)n²

Ô a õ



peéY>Y7iBn²

 D ¹

A

WYmáüUòJ/C/Cõ%I  ¾_éY>Y7#PY±b#PY7Kn²` L[ªT­LSI95/0<2òJ:8:6;&^U®

A

>Y9¥éY/CÀNcPn²

0 ø îj)ülUPéYY7n²

= Ù 

Ó

é¡WéYéYC>Y}kP±bXPn²

È ø ð

lúéYéYC>Y}kP>YýzÒ:Å?Yn²

ß ~ b

.

r´éYéYCÀNc$ãXP'ê$XP(n²%"$#&$"D

I(*D

(*
L

à _ P
Ð

]

éYYõ

Z ï hÊéYéYCÆÿ=ôXPn²

O þ ©

<

Ç£IòJã/CFQCõ

å L E

2

×_f'/CCõ ïHLéY/CyDÚX¤I77õ
'n²(

 L 

(

0¿>PéYXPYê)n²

 D ¹

A

WYmáüUòJ/C/Cõ%I Ä OÕ¦Ò'Y(
L>|FÒYHU¨$YõN;43/E!?>(*.
#ÌÞò,+"

CJ!<0(*.

*-$]ÛÁ3<4&úWs/CFQCõ

(*D

 L

6

GíAÌ*-}kTNH/CÀNcXP7õ



Í ~ |

A

ül>P§PéY!&n²(*ËC¡>¢TJ ? S_

lúéYéYC>Y}kPXPY%ÝXPn²

) Ã µ

2

tDéYéYCÒGPY}k7ÀNcXPYn²

O þ ©

<

Ç£IòJã/CFQCõ

å L E

2

×_f'/CCõ= ø AC>PéYÀNc$ã!%Ý$#;-XPYn²

ù f ½

 a j

A

lú3ï@>Y¤I3<4&3<4&õ

.

BVéY>Y7XPY¯&n²

  ·

Ï

'(*-}kTNH/C8Cõ$ÀNc3<4&õ

h ø _



d4éY>Y7±bXPn²'¶Mº(

４５$)5/3<+,!*,3).+1($0%/&#2-*'!,3).+1"
←

錦糸町

平井

→

JR亀戸駅
ドン・キホーテ

京葉道路
みずほ銀行

歩道橋

タニビル
事務局3階
セブンイレブン
もち吉

五之橋通り交差点

首都高速7号線
NTT

明治通り

←

新宿

Ａ２
出口★

本八幡

パン屋

→

西大島駅
江東区区民センター$136!0071 ;.:4;0-117>28=65 ()*+3,"2</8'369%&#!JR :D902.&'>F5E "FB1(?'H4='(C%#!@-7698;A.&'>F8E"H4='(G%##8>)10>?.5$!+'+':;&(!

)

47<9%,6-=*10/23"
JR gw]3Pm­¾Ã%²«CHi¾z&Fgw°4.QI;!v6H8ÀF.>QI;o§¼°ÁjF¨:A±G
¼C:A'±¼°Áj(".R/H'gw¼°Áj(C9SA/>O0B:>4"
È++¸FuGgw°C£:>=0B;!

t´yU2ÉQ:A2Q_­G°9IC:A¦6G¾#F:ISA2QI;!,rG_3P"lµF+**d[.R³G`4\¤F5L"±k\G³GÂ
C:A¶T/Us<I;4"|w©"gw
H¬B©j4U{K³U¥F1
PS|wGÂC:Ax©p}hy"º©
hy4¿S>fÇM.Q"¦6G½¡cE
DGªFMQ·SPSA/I;!²«Gn6FM7GO0E°Å4.QI;GB"²«G~nG

C\F"¡b¯FÄÂCE@>XWVYZ$U¹qC:A-rG³GÅ%f&Ua9<A®5I:>!²«F2^:G
FH¢»"Æ?e@AJAH/33B:N03!
４８